Amedeo Smart

Free Medical Literature Service

 

Amedeo

Osteoporosis
  Free Subscription

Articles published in
Osteoporos Int
    April 2024
  1. PRAVEEN AD, Aspelund T, Ferguson SJ, Sigurethsson S, et al
    Refracture and mortality risk in the elderly with osteoporotic fractures: the AGES-Reykjavik study.
    Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07096.
    >> Share

  2. GOLD DT, Beckett T, Deal C, James AL, et al
    Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study.
    Osteoporos Int. 2024 Apr 24. doi: 10.1007/s00198-024-07070.
    >> Share

  3. ZUBICK P, Dahlke S
    Family/caregiver influence on osteoporosis management for older people: an integrative review.
    Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07081.
    >> Share

  4. AGARWAL AR, Kinnard MJ, Murdock C, Zhao AY, et al
    The cost-effectiveness of osteoporosis medications for preventing periprosthetic fractures following femoral neck fracture indicated hip arthroplasty: a break-even analysis.
    Osteoporos Int. 2024 Apr 15. doi: 10.1007/s00198-024-07085.
    >> Share

  5. CHANDRAN M, Akesson KE, Javaid MK, Harvey N, et al
    Impact of osteoporosis and osteoporosis medications on fracture healing: a narrative review.
    Osteoporos Int. 2024 Apr 8. doi: 10.1007/s00198-024-07059.
    >> Share

  6. GIELEN E, Aldven M, Kanis JA, Borgstrom F, et al
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
    Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07043.
    >> Share

  7. ANAGNOSTIS P, Lallas K, Pappa A, Avgeris G, et al
    The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2024 Apr 2. doi: 10.1007/s00198-024-07075.
    >> Share

  8. FUJITA N, Ono Y, Hashimoto K, Kawamura Y, et al
    Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report.
    Osteoporos Int. 2024;35:733-736.
    >> Share

  9. WHITING PS, Hare K, Krueger D, Borchardt G, et al
    Periprosthetic fractures are osteoporotic fractures: missed opportunities for osteoporosis diagnosis.
    Osteoporos Int. 2024 Apr 1. doi: 10.1007/s00198-024-07057.
    >> Share

    March 2024
  10. KOBAYASHI T, Morimoto T, Mawatari M
    Factors influencing the measurement of sagittal spinopelvic alignment in patients with vertebral fractures.
    Osteoporos Int. 2024 Mar 29. doi: 10.1007/s00198-024-07063.
    >> Share

  11. CAI Y, Jun G, Zhuang X
    Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.
    Osteoporos Int. 2024 Mar 27. doi: 10.1007/s00198-023-07013.
    >> Share

  12. LORENTZON M, Litsne H, Axelsson KF
    The significance of recent fracture location for imminent risk of hip and vertebral fractures-a nationwide cohort study on older adults in Sweden.
    Osteoporos Int. 2024 Mar 23. doi: 10.1007/s00198-024-07072.
    >> Share

  13. LI D, Mao SS, Budoff MJ
    Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis.
    Osteoporos Int. 2024 Mar 22. doi: 10.1007/s00198-024-07040.
    >> Share

  14. PARK HJ, Kim MG, Yoo YS, Lee B, et al
    Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-analysis.
    Osteoporos Int. 2024 Mar 21. doi: 10.1007/s00198-024-07065.
    >> Share

  15. PLUSKIEWICZ W, Tabor E
    The comments on manuscript entitled 'Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study'.
    Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07056.
    >> Share

  16. DAS L, Laway BA, Sahoo J, Dhiman V, et al
    Bone mineral density, turnover, and microarchitecture assessed by second-generation high-resolution peripheral quantitative computed tomography in patients with Sheehan's syndrome.
    Osteoporos Int. 2024 Mar 20. doi: 10.1007/s00198-024-07062.
    >> Share

  17. MERLIJN T, Swart KMA, Niemeijer C, van der Horst HE, et al
    The yield of routine laboratory examination in osteoporosis evaluation in primary care.
    Osteoporos Int. 2024 Mar 18. doi: 10.1007/s00198-024-07042.
    >> Share

  18. TAGUCHI A
    Letters to the Editor for "Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study".
    Osteoporos Int. 2024 Mar 14. doi: 10.1007/s00198-024-07058.
    >> Share

  19. PARK HJ, Kim MG, Yoo YS, Lee BR, et al
    Determination of the Combined Effects of Asian Herbal Medicine with Calcium and/or Vitamin D Supplements on Bone Mineral Density in Primary Osteoporosis: A Systematic Review and Meta-Analysis.
    Osteoporos Int. 2024 Mar 13. doi: 10.1007/s00198-024-07061.
    >> Share

  20. HOLLOWAY-KEW KL, Betson AG, Anderson KB, Kotowicz MA, et al
    Associations between ultra-distal forearm bone mineral density and incident fracture in women.
    Osteoporos Int. 2024 Mar 6. doi: 10.1007/s00198-024-07041.
    >> Share

  21. CHEN L, Li C, Chen H, Xie Y, et al
    Cross-sectional studies of the causal link between asthma and osteoporosis: insights from Mendelian randomization and bioinformatics analysis.
    Osteoporos Int. 2024 Mar 2. doi: 10.1007/s00198-024-07037.
    >> Share

    February 2024
  22. BLAY R, Flores LE, Kupzyk K, Waltman N, et al
    Twelve-month resistance and impact exercise program or risedronate provides a relative benefit to hip bone structure in postmenopausal women: results from a randomized controlled trial.
    Osteoporos Int. 2024 Feb 17. doi: 10.1007/s00198-023-07008.
    >> Share

  23. PRAVEEN AD, Sollmann N, Baum T, Ferguson SJ, et al
    CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2024 Feb 14. doi: 10.1007/s00198-024-07029.
    >> Share

  24. ZHANG H, Yang F, Cao Z, Xu Y, et al
    The influence of iron on bone metabolism disorders.
    Osteoporos Int. 2024;35:243-253.
    >> Share

  25. YANG Q, He J, Yuan F
    Improvement of proportion of days covered for denosumab under implementation of clinical pharmacist adherence management system: normal and COVID-19 period.
    Osteoporos Int. 2024;35:309-316.
    >> Share

  26. RAMCHAND SK, Tsai JN, Lee H, Sassana-Khadka G, et al
    The comparison of alendronate and raloxifene after denosumab (CARD) study: A comparative efficacy trial.
    Osteoporos Int. 2024;35:255-263.
    >> Share

    January 2024
  27. EBINA K, Nagayama Y, Kashii M, Tsuboi H, et al
    An investigation of the differential therapeutic effects of romosozumab on postmenopausal osteoporosis patients with or without rheumatoid arthritis complications: a case-control study.
    Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07019.
    >> Share

  28. YU W, Guan WM, Hayashi D, Lin Q, et al
    Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique.
    Osteoporos Int. 2024 Jan 31. doi: 10.1007/s00198-024-07024.
    >> Share

  29. CUNHA-SANTOS F, Augusto D, Pinto AS, Dinis SP, et al
    Predictors of atypical femoral fractures: experience of a Portuguese Fracture Liaison Service.
    Osteoporos Int. 2024 Jan 29. doi: 10.1007/s00198-024-07033.
    >> Share

  30. BENNETT MJ, Center JR, Perry L
    Establishing consensus recommendations for long-term osteoporosis care for patients who have attended an Australian fracture liaison service: a Delphi study.
    Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07014.
    >> Share

  31. SILVA FF, Machado GR, Ribeiro ACM, Bonfiglioli KR, et al
    Damaged bone microarchitecture by Trabecular Bone Score (TBS) and low appendicular muscle mass: main risk factors for vertebral and non-vertebral fractures in women with long-standing rheumatoid arthritis.
    Osteoporos Int. 2024 Jan 25. doi: 10.1007/s00198-024-07026.
    >> Share

  32. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
    Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwi
    Osteoporos Int. 2024 Jan 24. doi: 10.1007/s00198-024-07023.
    >> Share

  33. JEON S, Yu D, Kim S, Kim SW, et al
    Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture.
    Osteoporos Int. 2024 Jan 23. doi: 10.1007/s00198-024-07025.
    >> Share

  34. CAO X, Keyak JH, Sigurdsson S, Zhao C, et al
    A new hip fracture risk index derived from FEA-computed proximal femur fracture loads and energies-to-failure.
    Osteoporos Int. 2024 Jan 22. doi: 10.1007/s00198-024-07015.
    >> Share

  35. BYUN SE, Kim H, Lee SY, Kim SM, et al
    Selective estrogen receptor modulators (SERMs) with vitamin D composite agent can prevent fracture better than SERMs treatment: based on the National Health Claims Database 2017-2019.
    Osteoporos Int. 2024 Jan 19. doi: 10.1007/s00198-024-07022.
    >> Share

  36. SKJODT MK, Nicolaes J, Smith CD, Olsen KR, et al
    Opportunistically identifiable vertebral fractures on routine radiological imaging predict mortality: observational cohort study.
    Osteoporos Int. 2024 Jan 18. doi: 10.1007/s00198-024-07017.
    >> Share

  37. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
    A meta-analysis of previous falls and subsequent fracture risk in cohort studies.
    Osteoporos Int. 2024 Jan 17. doi: 10.1007/s00198-023-07012.
    >> Share

  38. ZENG L, Li Y, Hong C, Wang J, et al
    Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies.
    Osteoporos Int. 2024 Jan 15. doi: 10.1007/s00198-023-06996.
    >> Share

  39. LEUNG MTY, Turner JP, Marquina C, Ilomaki J, et al
    Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study.
    Osteoporos Int. 2024 Jan 10. doi: 10.1007/s00198-023-06974.
    >> Share

  40. CHOO YW, Mohd Tahir NA, Mohamed Said MS, Makmor Bakry M, et al
    Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41.
    Osteoporos Int. 2024 Jan 9. doi: 10.1007/s00198-023-07005.
    >> Share

  41. MULKERRIN P, O'Shea F, Fitzgerald G
    Comment on: Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
    Osteoporos Int. 2024 Jan 8. doi: 10.1007/s00198-023-07010.
    >> Share

    December 2023
  42. MCCARROLL K, Fitzpatrick D, McCormack M, Abdelfadil S, et al
    Falsely elevated parathyroid hormone in a patient with osteoporosis: a case report and review.
    Osteoporos Int. 2023 Dec 28. doi: 10.1007/s00198-023-07006.
    >> Share

  43. CHEN H, Zhu X, Zhou Q, Pu X, et al
    Utility of MRI-based vertebral bone quality scores and CT-based Hounsfield unit values in vertebral bone mineral density assessment for patients with diffuse idiopathic skeletal hyperostosis.
    Osteoporos Int. 2023 Dec 27. doi: 10.1007/s00198-023-06999.
    >> Share

  44. MAKRAS P, Yavropoulou MP, Anastasilakis AD, Papatheodorou A, et al
    Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment.
    Osteoporos Int. 2023 Dec 26. doi: 10.1007/s00198-023-07000.
    >> Share

  45. DING W, Huang Y, Li G, Dong Y, et al
    Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma: from genetic and prospective evidence.
    Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-07004.
    >> Share

  46. MAGNO LAV, Tameirao DR, Alves LF, Guimaraes NS, et al
    Effect of recreational cannabis use on bone mineral density: a systematic review.
    Osteoporos Int. 2023 Dec 23. doi: 10.1007/s00198-023-06992.
    >> Share

  47. CHAVASSIEUX P, Roux JP, Chapurlat R
    Pre-treatment bone turnover does not influence the level of the response to alendronate in postmenopausal osteoporosis at the bone tissue level.
    Osteoporos Int. 2023 Dec 22. doi: 10.1007/s00198-023-06972.
    >> Share

  48. YOKOYAMA K, Ikeda N, Tanaka H, Ito Y, et al
    Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture.
    Osteoporos Int. 2023 Dec 18. doi: 10.1007/s00198-023-06976.
    >> Share

  49. YOO JE, Huh Y, Kim E, Park SH, et al
    Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study.
    Osteoporos Int. 2023 Dec 14. doi: 10.1007/s00198-023-06983.
    >> Share

  50. GUIMARAES GC, Coelho JBC, Silva JGO, de Sant'Ana ACC, et al
    Obesity, diabetes and risk of bone fragility: How BMAT behavior is affected by metabolic disturbances and its influence on bone health.
    Osteoporos Int. 2023 Dec 6. doi: 10.1007/s00198-023-06991.
    >> Share

  51. HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
    Geographic variation in bone mineral density and prevalent fractures in the Canadian longitudinal study on aging.
    Osteoporos Int. 2023 Dec 2. doi: 10.1007/s00198-023-06975.
    >> Share

    November 2023
  52. NIZNIK JD, Kelley CJ, Fasth L, Colon-Emeric C, et al
    Deprescribing bisphosphonates for older adults with dementia: perspectives of caregivers.
    Osteoporos Int. 2023 Nov 18. doi: 10.1007/s00198-023-06967.
    >> Share

  53. BEAUDART C, Sharma M, Clark P, Fujiwara S, et al
    Patients' preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study.
    Osteoporos Int. 2023 Nov 13. doi: 10.1007/s00198-023-06955.
    >> Share

  54. CHEN KH, Su CM, Liu WJ, Tzeng HE, et al
    The joint effects of physical activity and sleep duration on risk of osteoporosis in Taiwanese adult population: The Taiwan Biobank Study.
    Osteoporos Int. 2023 Nov 10. doi: 10.1007/s00198-023-06947.
    >> Share

  55. KONNOPKA C, Buchele G, Jaensch A, Rothenbacher D, et al
    Evaluation of costs, osteoporosis treatment, and re-fractures in German collaborative orthogeriatric care after fragility fractures.
    Osteoporos Int. 2023 Nov 9. doi: 10.1007/s00198-023-06965.
    >> Share

  56. NAJAFI S, Mohammadkhah F, Ebrahimi MM, Harsini PA, et al
    Effect of educational intervention on preventing osteoporosis in postmenopausal women.
    Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06962.
    >> Share

  57. AGARWAL AR, Tarawneh O, Cohen JS, Gu A, et al
    The incremental risk of fragility fractures in aging men.
    Osteoporos Int. 2023 Nov 8. doi: 10.1007/s00198-023-06956.
    >> Share

  58. CHEN Q, Tu Z, Ai Y, Li W, et al
    Forearm bone mineral density predicts screw loosening after lumbar fusion similar to lumbar Hounsfield unit value in patients with lumbar spondylolisthesis.
    Osteoporos Int. 2023 Nov 3. doi: 10.1007/s00198-023-06957.
    >> Share

    October 2023
  59. HAN S, Kim S, Yeh EJ, Suh HS, et al
    Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.
    Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06934.
    >> Share

  60. INPAN R, Na Takuathung M, Sakuludomkan W, Dukaew N, et al
    Isoflavone intervention and its impact on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2023 Oct 25. doi: 10.1007/s00198-023-06944.
    >> Share

  61. HEUCHERT J, Koziel S, Spinek AE
    Radiomorphometric indices of the mandible as indicators of decreased bone mineral density and osteoporosis - meta-analysis and systematic review.
    Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06949.
    >> Share

  62. LOSCALZO E, See J, Bharill S, Yousefzadeh N, et al
    Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids.
    Osteoporos Int. 2023 Oct 23. doi: 10.1007/s00198-023-06951.
    >> Share

  63. KYVERNITAKIS I, Reuter TC, Hellmeyer L, Hars O, et al
    Correction to: Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06927.
    >> Share

  64. KOVACS CS
    Fraudulent, duplicate publication of pregnancy/lactation data in Osteoporosis International.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06939.
    >> Share

  65. ZERAATTALAB-MOTLAGH S, Mortazavi AS, Ghoreishy SM, Mohammadi H, et al
    Association between total and animal proteins with risk of fracture: A systematic review and dose-response meta-analysis of cohort studies.
    Osteoporos Int. 2023 Oct 19. doi: 10.1007/s00198-023-06948.
    >> Share

  66. PLAIS N, Bustos JG, Mahillo-Fernandez I, Tome-Bermejo F, et al
    Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment.
    Osteoporos Int. 2023 Oct 13. doi: 10.1007/s00198-023-06936.
    >> Share

  67. GROVLE L, Haugen AJ, Johansen M, Hasvik E, et al
    The terminologies of transient, migratory, or localized osteoporosis, and bone marrow edema syndrome: a scoping review.
    Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06929.
    >> Share

  68. YAN F, Wu L, Lang J, Huang Z, et al
    Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.
    Osteoporos Int. 2023 Oct 9. doi: 10.1007/s00198-023-06925.
    >> Share

  69. LI N, van den Bergh JP, Boonen A, Wyers CE, et al
    Cost-effectiveness analysis of fracture liaison services: a Markov model using Dutch real-world data.
    Osteoporos Int. 2023 Oct 3. doi: 10.1007/s00198-023-06924.
    >> Share

  70. MAKRAS P, Yavropoulou MP, Polyzos SA, Papapoulos SE, et al
    The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.
    Osteoporos Int. 2023 Oct 2. doi: 10.1007/s00198-023-06931.
    >> Share

  71. OTEO-ALVARO A, Garcia CG, Sanchez AI, Santamaria CA, et al
    Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).
    Osteoporos Int. 2023;34:1799-1804.
    >> Share

  72. BAGHERIFARD A, Hosseinzadeh A, Koosha F, Sheibani M, et al
    Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.
    Osteoporos Int. 2023;34:1677-1701.
    >> Share

    September 2023
  73. MAAS L, Raskin N, van Onna M, Cornelissen D, et al
    Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture.
    Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06906.
    >> Share

  74. SOLOMON DH, Ruppert K, Cauley JA, Lian Y, et al
    The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women's Health Across the Nation (SWAN).
    Osteoporos Int. 2023 Sep 21. doi: 10.1007/s00198-023-06915.
    >> Share

  75. HUNG WC, Lin YL, Cheng TT, Chin WL, et al
    Establish and validate the reliability of predictive models in bone mineral density by deep learning as examination tool for women.
    Osteoporos Int. 2023 Sep 20. doi: 10.1007/s00198-023-06913.
    >> Share

  76. FUJISHIMA R, Ushimaru S, Sumi H, Aso M, et al
    Effect of denosumab on bone mineral density in a postmenopausal osteoporotic woman with prolonged chronic mild hyponatremia.
    Osteoporos Int. 2023 Sep 19. doi: 10.1007/s00198-023-06898.
    >> Share

  77. LIU X, Makaroff KE, Almario CV, Khalil C, et al
    Determining patient preferences for the medical management of osteoporosis using conjoint analysis.
    Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06882.
    >> Share

  78. ELWAKIL W, El Gaafary M, El Miedany Y
    Screening and management of osteoporosis: a survey of knowledge, attitude, and practice among healthcare professionals in Egypt-a study by the Egyptian Academy of Bone Health.
    Osteoporos Int. 2023 Sep 18. doi: 10.1007/s00198-023-06914.
    >> Share

  79. CLIFTON GOLDNEY D, Pelegrin C, Jerkovich F, Longobardi V, et al
    Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series.
    Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06894.
    >> Share

  80. LEE RH, Curtis J, Drake MT, Bobo Tanner S 4th, et al
    Association of prior treatment with nitrogen-containing bisphosphonates on outcomes of COVID-19 positive patients.
    Osteoporos Int. 2023 Sep 13. doi: 10.1007/s00198-023-06912.
    >> Share

  81. LU K, Wu YM, Shi Q, Gong YQ, et al
    A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients.
    Osteoporos Int. 2023 Sep 12. doi: 10.1007/s00198-023-06905.
    >> Share

  82. NICOLAES J, Liu Y, Zhao Y, Huang P, et al
    External validation of a convolutional neural network algorithm for opportunistically detecting vertebral fractures in routine CT scans.
    Osteoporos Int. 2023 Sep 7. doi: 10.1007/s00198-023-06903.
    >> Share

  83. PENG T, Zeng X, Li Y, Li M, et al
    A study on whether deep learning models based on CT images for bone density classification and prediction can be used for opportunistic osteoporosis screening.
    Osteoporos Int. 2023 Sep 5. doi: 10.1007/s00198-023-06900.
    >> Share

  84. LIU J, Tang Y, Peng B, Tian C, et al
    Bone mineral density is associated with composite dietary antioxidant index among US adults: results from NHANES.
    Osteoporos Int. 2023 Sep 4. doi: 10.1007/s00198-023-06901.
    >> Share

  85. KARPUZ S
    Zoledronic acid-induced severe lymphopenia.
    Osteoporos Int. 2023;34:1653-1655.
    >> Share

    August 2023
  86. MOAYYERI A, Warden J, Han S, Suh HS, et al
    Estimating the economic burden of osteoporotic fractures in a multinational study: a real-world data perspective.
    Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06895.
    >> Share

  87. WANG J, Xing F, Sheng N, Xiang Z, et al
    Associations of dietary oxidative balance score with femur osteoporosis in postmenopausal women: data from the National Health and Nutrition Examination Survey.
    Osteoporos Int. 2023 Aug 31. doi: 10.1007/s00198-023-06896.
    >> Share

  88. SHAHROUR E
    A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy).
    Osteoporos Int. 2023 Aug 30. doi: 10.1007/s00198-023-06876.
    >> Share

  89. BILLINGTON EO, Miyagishima RC, Hasselaar C, Arain M, et al
    Women's perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study.
    Osteoporos Int. 2023 Aug 22. doi: 10.1007/s00198-023-06890.
    >> Share

  90. BARCELOS A, Goncalves J, Mateus C, Canhao H, et al
    Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective.
    Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06881.
    >> Share

  91. HONG N, Shin S, Lee S, Rhee Y, et al
    Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis.
    Osteoporos Int. 2023 Aug 19. doi: 10.1007/s00198-023-06889.
    >> Share

  92. ABDALBARY M, El-Husseini A
    Author response to: Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06874.
    >> Share

  93. TURABI RY, Sheehan KJ
    Response letter to: "The importance of structural barriers of osteoporotic hip fracture in the elderly".
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06864.
    >> Share

  94. MARTINS MJ
    Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study. Osteoporos Int. 2023 Apr;34(4):763-774.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06873.
    >> Share

  95. MEIJIDE H, Gredilla I, Cachorro I, Robert I, et al
    The importance of structural barriers of osteoporotic hip fracture in the elderly.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06875.
    >> Share

  96. LI W, Zhao H, Zhou S, Xiong Z, et al
    Does vertebral osteoporosis delay or accelerate lumbar disc degeneration? A systematic review.
    Osteoporos Int. 2023 Aug 14. doi: 10.1007/s00198-023-06880.
    >> Share

  97. KANIS JA, Johansson H, McCloskey EV, Liu E, et al
    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX.
    Osteoporos Int. 2023 Aug 11. doi: 10.1007/s00198-023-06870.
    >> Share

  98. SEO DH, Jeong Y, Cho Y, Kim SH, et al
    Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults.
    Osteoporos Int. 2023 Aug 8. doi: 10.1007/s00198-023-06879.
    >> Share

  99. FITZPATRICK D, Seebah S, Lannon R, Mc Carroll K, et al
    Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naive patients: two further cases.
    Osteoporos Int. 2023 Aug 1. doi: 10.1007/s00198-023-06869.
    >> Share

    July 2023
  100. HE D, Liu H, Wei W, Zhao Y, et al
    A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank.
    Osteoporos Int. 2023 Jul 27. doi: 10.1007/s00198-023-06852.
    >> Share

  101. THERKILDSEN J, Rohde PD, Nissen L, Thygesen J, et al
    A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density.
    Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06857.
    >> Share

  102. EVERTS-GRABER J, Bonel H, Lehmann D, Gahl B, et al
    Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Osteoporos Int. 2023 Jul 26. doi: 10.1007/s00198-023-06863.
    >> Share

  103. MAZEDA C, Barcelos A
    Gender differences in osteoporosis.
    Osteoporos Int. 2023 Jul 20. doi: 10.1007/s00198-023-06858.
    >> Share

  104. TAN EH, Robinson DE, Jodicke AM, Mosseveld M, et al
    Drug utilization analysis of osteoporosis medications in seven European electronic health databases.
    Osteoporos Int. 2023 Jul 12. doi: 10.1007/s00198-023-06837.
    >> Share

  105. SCHUMM AK, Craige EA, Arora NK, Owen PJ, et al
    Does adding exercise or physical activity to pharmacological osteoporosis therapy in patients with increased fracture risk improve bone mineral density and lower fracture risk? A systematic review and meta-analysis.
    Osteoporos Int. 2023 Jul 11. doi: 10.1007/s00198-023-06829.
    >> Share

  106. HASEGAWA T
    Author response to OSIN-D-23-00510, "Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wo
    Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06835.
    >> Share

  107. SOMAY E
    Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really
    Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06821.
    >> Share

  108. JAVAID MK, Pinedo-Villanueva R, Shah A, Mohsin Z, et al
    The Capture the Fracture(R) Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit.
    Osteoporos Int. 2023 Jul 7. doi: 10.1007/s00198-023-06759.
    >> Share

  109. SHEVROJA E, Reginster JY, Lamy O, Al-Daghri N, et al
    Update on the clinical use of trabecular bone score (TBS) in the management of osteoporosis: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Dis
    Osteoporos Int. 2023 Jul 1. doi: 10.1007/s00198-023-06817.
    >> Share

    June 2023
  110. SCHOUSBOE JT, Binkley N, Leslie WD
    Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture.
    Osteoporos Int. 2023 Jun 28. doi: 10.1007/s00198-023-06820.
    >> Share

  111. MOON RJ, Reginster JY, Al-Daghri NM, Thiyagarajan JA, et al
    Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).
    Osteoporos Int. 2023 Jun 23. doi: 10.1007/s00198-023-06827.
    >> Share

  112. KADRI A, Binkley N, Hernando D, Anderson PA, et al
    Author response to letter to editor: OSIN-D-23-00474, "letter to the editor regarding 'Opportunistic use of lumbar magnetic resonance imaging for osteoporosis screening'".
    Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06808.
    >> Share

  113. PU X, Li H
    Letter to the editor regarding "Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening".
    Osteoporos Int. 2023 Jun 21. doi: 10.1007/s00198-023-06801.
    >> Share

  114. LIU FC, Luk KC, Chen YC
    Risk comparison of osteonecrosis of the jaw in osteoporotic patients treated with bisphosphonates vs. denosumab: a multi-institutional retrospective cohort study in Taiwan.
    Osteoporos Int. 2023 Jun 16. doi: 10.1007/s00198-023-06818.
    >> Share

  115. HUANG G, Chen X, Chen Y, Liu W, et al
    Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population.
    Osteoporos Int. 2023 Jun 12. doi: 10.1007/s00198-023-06807.
    >> Share

  116. PASKINS Z, Moult A, Corp N, Bastounis A, et al
    Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise.
    Osteoporos Int. 2023 Jun 9. doi: 10.1007/s00198-023-06806.
    >> Share

  117. HESARI E, Sanjari M, Mansourzadeh MJ, Fahimfar N, et al
    Osteoporosis medication adherence tools: a systematic review.
    Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06789.
    >> Share

  118. HAGINO H, Moriwaki K, Wada T, Osaki M, et al
    Urinary pentosidine level is associated with the risk of fracture in community-dwelling older adults: a prospective observational study.
    Osteoporos Int. 2023 Jun 8. doi: 10.1007/s00198-023-06816.
    >> Share

  119. KUNIHARA T, Tohmori H, Tsukamoto M, Kobayashi M, et al
    Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan.
    Osteoporos Int. 2023;34:1101-1109.
    >> Share

    May 2023
  120. LIN SM, Lin JY, Tu YK, Wu CH, et al
    Association between bisphosphonate use and stroke risk: a meta-analysis.
    Osteoporos Int. 2023 May 30. doi: 10.1007/s00198-023-06781.
    >> Share

  121. LU K, Wu YM, Shi Q, Gong YQ, et al
    The impact of acute-phase reaction on mortality and re-fracture after zoledronic acid in hospitalized elderly osteoporotic fracture patients.
    Osteoporos Int. 2023 May 29. doi: 10.1007/s00198-023-06803.
    >> Share

  122. GOLD LS, Suri P, O'Reilly MK, Kallmes DF, et al
    Mortality among older adults with osteoporotic vertebral fracture.
    Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06796.
    >> Share

  123. ZHU K, Hunter M, James A, Lim EM, et al
    Relationships between longitudinal changes in body composition and bone mineral density in middle-to-older aged Australians.
    Osteoporos Int. 2023 May 26. doi: 10.1007/s00198-023-06773.
    >> Share

  124. LAI SW
    Adipopenia associated with osteoporosis.
    Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06797.
    >> Share

  125. KWON H, Han KD, Kim BS, Moon SJ, et al
    Acromegaly and the long-term fracture risk of the vertebra and hip: a national cohort study.
    Osteoporos Int. 2023 May 24. doi: 10.1007/s00198-023-06800.
    >> Share

  126. RASHIDI MM, Saeedi Moghaddam S, Azadnajafabad S, Heidari-Foroozan M, et al
    Low bone mineral density, a neglected condition in North Africa and Middle East: estimates from the Global Burden of Disease Study, 1990-2019.
    Osteoporos Int. 2023 May 23. doi: 10.1007/s00198-023-06778.
    >> Share

  127. KONDAPALLI AV, Kamanda-Kosseh M, Williams JM, Shiau S, et al
    Clinical characteristics of pregnancy and lactation associated osteoporosis: An online survey study.
    Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06793.
    >> Share

  128. YANG H, Bai J, Li L, Yang Y, et al
    Association of C-peptide level with bone mineral density in type 2 diabetes mellitus.
    Osteoporos Int. 2023 May 19. doi: 10.1007/s00198-023-06785.
    >> Share

  129. AGARWAL AR, Cohen JS, Tarawneh OH, Gu A, et al
    The impact of prior fragility fractures on long-term periprosthetic fracture risk following total knee arthroplasty.
    Osteoporos Int. 2023 May 11. doi: 10.1007/s00198-023-06746.
    >> Share

  130. AVGERINOU C, Petersen I, Clegg A, West RM, et al
    Trends in incidence of recorded diagnosis of osteoporosis, osteopenia, and fragility fractures in people aged 50 years and above: retrospective cohort study using UK primary care data.
    Osteoporos Int. 2023 May 10. doi: 10.1007/s00198-023-06739.
    >> Share

  131. METRAILLER A, Hans D, Lamy O, Gonzalez Rodriguez E, et al
    Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study.
    Osteoporos Int. 2023 May 8. doi: 10.1007/s00198-023-06728.
    >> Share

    April 2023
  132. HO-PHAM LT, Nguyen HG, Nguyen-Pham SQ, Hoang DK, et al
    Longitudinal changes in bone mineral density during perimenopausal transition: the Vietnam Osteoporosis Study.
    Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06757.
    >> Share

  133. RISKA BSL, Gunnes N, Stigum H, Finnes TE, et al
    Time-varying exposure to anti-osteoporosis drugs and risk of first-time hip fracture: a population wide study within the Norwegian Epidemiologic Osteoporosis Studies (NOREPOS).
    Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06752.
    >> Share

  134. MOON RJ, Green HD, D'Angelo S, Godfrey KM, et al
    The effect of pregnancy vitamin D supplementation on offspring bone mineral density in childhood: a systematic review and meta-analysis.
    Osteoporos Int. 2023 Apr 27. doi: 10.1007/s00198-023-06751.
    >> Share

  135. BENNETT MJ, Center JR, Perry L
    Exploring barriers and opportunities to improve osteoporosis care across the acute-to-primary care interface: a qualitative study.
    Osteoporos Int. 2023 Apr 24. doi: 10.1007/s00198-023-06748.
    >> Share

  136. HILL EC, O'Donnell L
    Low bone mineral density is associated with fatty liver disease and respiratory illness in a pediatric mortality sample.
    Osteoporos Int. 2023 Apr 21. doi: 10.1007/s00198-023-06760.
    >> Share

  137. CHANG CM, Chen YC, Wu WT, Lin TK, et al
    Association between clinical use of nifedipine and the risk of osteoporosis: a nationwide retrospective cohort study.
    Osteoporos Int. 2023 Apr 20. doi: 10.1007/s00198-023-06756.
    >> Share

  138. HASEGAWA T, Kawakita A, Ueda N, Funahara R, et al
    Correction to: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday rea
    Osteoporos Int. 2023 Apr 13. doi: 10.1007/s00198-023-06745.
    >> Share

  139. PONZANO M, Tibert N, Brien S, Funnell L, et al
    Publisher Correction: International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
    Osteoporos Int. 2023 Apr 10. doi: 10.1007/s00198-023-06717.
    >> Share

  140. ICONARU L, Charles A, Baleanu F, Moreau M, et al
    Selection for treatment of patients at high risk of fracture by the short versus long term prediction models - data from the Belgian FRISBEE cohort.
    Osteoporos Int. 2023 Apr 6. doi: 10.1007/s00198-023-06737.
    >> Share

  141. KHAN AA, AbuAlrob H, Al-Alwani H, Ali DS, et al
    Post hip fracture orthogeriatric care-a Canadian position paper addressing challenges in care and strategies to meet quality indicators.
    Osteoporos Int. 2023 Apr 4. doi: 10.1007/s00198-022-06640.
    >> Share

  142. TANG Y, Zhang L, Ye D, Zhao A, et al
    Causal relationship between Type 1 diabetes and osteoporosis and fracture occurrence: a two-sample Mendelian randomization analysis.
    Osteoporos Int. 2023 Apr 3. doi: 10.1007/s00198-023-06734.
    >> Share

  143. MATTICK LJ, Bea JW, Hovey KM, Wactawski-Wende J, et al
    Follicle-stimulating hormone is associated with low bone mass in postmenopausal women.
    Osteoporos Int. 2023;34:693-701.
    >> Share

    March 2023
  144. LEGRAND A, Autrusseau F, Bandiaky ON, Idiri K, et al
    Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in osteoporosis: toward a complementary populational screening tool managed by dentists?
    Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06724.
    >> Share

  145. NICKEL B, Krueger D, Borchardt G, Andersen L, et al
    Intraoperative physician assessment of bone: correlation to bone mineral density.
    Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06729.
    >> Share

  146. GOEL H, Binkley N, Hans D, Leslie WD, et al
    Bone density and trabecular bone score to predict fractures in adults aged 20-39 years: a registry-based study.
    Osteoporos Int. 2023 Mar 31. doi: 10.1007/s00198-023-06722.
    >> Share

  147. LIN Z, Shi G, Liao X, Liu W, et al
    Effect of pulmonary function on bone mineral density in the United States: results from the NHANES 2007-2010 study.
    Osteoporos Int. 2023 Mar 23. doi: 10.1007/s00198-023-06727.
    >> Share

  148. BINKLEY N, Nickel B, Anderson PA
    Periprosthetic fractures: an unrecognized osteoporosis crisis.
    Osteoporos Int. 2023 Mar 20. doi: 10.1007/s00198-023-06695.
    >> Share

  149. BRUHN R, Pedersen AB, Heide-Jorgensen U, Ehrenstein V, et al
    Epidemiology of male osteoporosis in Denmark (1996-2018).
    Osteoporos Int. 2023 Mar 13. doi: 10.1007/s00198-023-06720.
    >> Share

  150. EISMAN JA, Cortet B, Boolell M, Ionescu-Ittu R, et al
    Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
    Osteoporos Int. 2023 Mar 6. doi: 10.1007/s00198-022-06627.
    >> Share

  151. HANS D, McDermott M, Huang S, Kim M, et al
    Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness-adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-label extension.
    Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06708.
    >> Share

  152. TALEVSKI J, Gianoudis J, Bailey CA, Ebeling PR, et al
    Effects of an 18-month community-based, multifaceted, exercise program on patient-reported outcomes in older adults at risk of fracture: secondary analysis of a randomised controlled trial.
    Osteoporos Int. 2023 Mar 2. doi: 10.1007/s00198-023-06693.
    >> Share

  153. HU J, Li Y, Wang Z, Li X, et al
    Association of plant-based dietary patterns with the risk of osteoporosis in community-dwelling adults over 60 years: a cross-sectional study.
    Osteoporos Int. 2023 Mar 1. doi: 10.1007/s00198-023-06700.
    >> Share

    February 2023
  154. JUNG SY, Cho EB, Han KD, Jung JH, et al
    Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea.
    Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06715.
    >> Share

  155. HE D, Pan C, Zhao Y, Wei W, et al
    Exome-wide screening identifies novel rare risk variants for bone mineral density.
    Osteoporos Int. 2023 Feb 28. doi: 10.1007/s00198-023-06710.
    >> Share

  156. XIAO X, Wu Q
    Ethnic disparities in fracture risk assessment using polygenic scores.
    Osteoporos Int. 2023 Feb 25. doi: 10.1007/s00198-023-06712.
    >> Share

  157. HSU SC, Feng SH, Pan SL
    Risk of developing age-related macular degeneration in patients with osteoporosis: a population-based, longitudinal follow-up study.
    Osteoporos Int. 2023 Feb 24. doi: 10.1007/s00198-023-06711.
    >> Share

  158. PARASKEVOPOULOS K, Keskinis A, Vasios IS, Makiev KG, et al
    Letter to the editor regarding "Comparison of various treatment modalities for the management of bone marrow edema syndrome or transient osteoporosis in men and nonpregnant women: a systematic review".
    Osteoporos Int. 2023 Feb 22. doi: 10.1007/s00198-023-06705.
    >> Share

  159. ARASU K, Chang CY, Wong SY, Ong SH, et al
    Effect of soluble corn fibre and calcium supplementation on bone mineral content and bone mineral density in preadolescent Malaysian children-a double-blind randomised controlled trial (PREBONE-Kids Study).
    Osteoporos Int. 2023 Feb 21. doi: 10.1007/s00198-023-06702.
    >> Share

  160. PONZANO M, Tibert N, Brien S, Funnell L, et al
    International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures.
    Osteoporos Int. 2023 Feb 17. doi: 10.1007/s00198-023-06688.
    >> Share

  161. KUTLESA Z, Ordulj I, Peric I, Jerkovic K, et al
    Opportunistic measures of bone mineral density at multiple skeletal sites during whole-body CT in polytrauma patients.
    Osteoporos Int. 2023 Feb 17. doi: 10.1007/s00198-023-06699.
    >> Share

  162. ABDALBARY M, Chishti E, Shakhashiro M, Mohamed R, et al
    Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.
    Osteoporos Int. 2023 Feb 15. doi: 10.1007/s00198-023-06686.
    >> Share

  163. MOHEBBI R, Shojaa M, Kohl M, von Stengel S, et al
    Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators.
    Osteoporos Int. 2023 Feb 7. doi: 10.1007/s00198-023-06682.
    >> Share

  164. LIN M, Wen X, Huang Z, Huang W, et al
    A nomogram for predicting residual low back pain after percutaneous kyphoplasty in osteoporotic vertebral compression fractures.
    Osteoporos Int. 2023 Feb 4. doi: 10.1007/s00198-023-06681.
    >> Share

  165. CHANDRAN M, Brind'Amour K, Fujiwara S, Ha YC, et al
    Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific region: a systematic review.
    Osteoporos Int. 2023 Feb 3. doi: 10.1007/s00198-022-06657.
    >> Share

  166. CIRNIGLIARO CM, La Fountaine MF, Parrott JS, Kirshblum SC, et al
    Loss of lower extremity bone mineral density 1 year after denosumab is discontinued in persons with subacute spinal cord injury.
    Osteoporos Int. 2023 Feb 3. doi: 10.1007/s00198-023-06679.
    >> Share

  167. ARMSTRONG P, Kuo YF, Cram P, Westra J, et al
    National trends in osteoporosis medication use among Medicare beneficiaries with and without Alzheimer's disease/related dementias.
    Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06680.
    >> Share

  168. YE C, Lee K, Leslie WD, Lin M, et al
    Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event.
    Osteoporos Int. 2023 Feb 2. doi: 10.1007/s00198-023-06690.
    >> Share

  169. CLEMINSON JR, Pasco JA, Bortolasci CC, Holloway-Kew KL, et al
    Lipopolysaccharide-binding protein and bone health: data from a population-based sample of men.
    Osteoporos Int. 2023;34:309-317.
    >> Share

  170. MARINI F, Giusti F, Palmini G, Brandi ML, et al
    Role of Wnt signaling and sclerostin in bone and as therapeutic targets in skeletal disorders.
    Osteoporos Int. 2023;34:213-238.
    >> Share

    January 2023
  171. LIU J, Tang Y, Feng Z, Chen Y, et al
    Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018.
    Osteoporos Int. 2023 Jan 31. doi: 10.1007/s00198-023-06687.
    >> Share

  172. MUGNIER B, Goncalves A, Daumas A, Couderc AL, et al
    Prevention of aromatase inhibitor-induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer.
    Osteoporos Int. 2023 Jan 30. doi: 10.1007/s00198-023-06683.
    >> Share

  173. VERDONCK C, Willems R, Borgermans L
    Implementation and operationalization of Integrated People-Centred Health Services delivery strategies in integrated osteoporosis care (IOC) initiatives: a systematic review.
    Osteoporos Int. 2023 Jan 25. doi: 10.1007/s00198-023-06678.
    >> Share

  174. KHAN MI
    Management of bone loss due to endocrine therapy during cancer treatment.
    Osteoporos Int. 2023 Jan 19. doi: 10.1007/s00198-023-06672.
    >> Share

  175. BELAYA Z, Rozhinskaya L, Dedov I, Drapkina O, et al
    A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis.
    Osteoporos Int. 2023 Jan 18. doi: 10.1007/s00198-022-06667.
    >> Share

  176. XIAO X, Wu Q
    The clinical utility of the BMD-related comprehensive genome-wide polygenic score in identifying individuals with a high risk of osteoporotic fractures.
    Osteoporos Int. 2023 Jan 9. doi: 10.1007/s00198-022-06654.
    >> Share

  177. KIM KJ, Hong N, Lee S, Shin S, et al
    Exploratory use of romosozumab for osteoporosis in a patient with Hajdu-Cheney syndrome: a case report.
    Osteoporos Int. 2023 Jan 9. doi: 10.1007/s00198-023-06668.
    >> Share

  178. TUTAWORN T, Nieves JW, Wang Z, Levin JE, et al
    Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study.
    Osteoporos Int. 2023 Jan 5:1-12. doi: 10.1007/s00198-022-06648.
    >> Share

  179. AUAIS M, Angermann H, Grubb M, Thomas C, et al
    The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review.
    Osteoporos Int. 2023 Jan 4. doi: 10.1007/s00198-022-06659.
    >> Share

  180. KRAVVARITI E, Kasdagli MI, Diomatari KM, Mouratidou P, et al
    Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice.
    Osteoporos Int. 2023 Jan 4. doi: 10.1007/s00198-022-06658.
    >> Share

  181. CHANG E, Binkley N, Krueger D, Illgen R, et al
    Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA.
    Osteoporos Int. 2023;34:171-177.
    >> Share

  182. GRAUMAM RQ, Pinheiro MM, Szejnfeld VL, Nery LE, et al
    High rate of abdominal aortic calcification in COPD patients and its relationship with musculoskeletal fragility.
    Osteoporos Int. 2023;34:69-79.
    >> Share

    December 2022
  183. KASHII M, Kamatani T, Nagayama Y, Miyama A, et al
    Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis.
    Osteoporos Int. 2022 Dec 31. doi: 10.1007/s00198-022-06642.
    >> Share

  184. TENG PF, Chiang JM, Schafer AL, Sukerkar PA, et al
    Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT).
    Osteoporos Int. 2022 Dec 29. doi: 10.1007/s00198-022-06624.
    >> Share

  185. NEWSON L, Ball S, Lewis R
    Letter to Editor: Our concerns about HRT not having a priority as a treatment for osteoporosis in the NOGG guidelines.
    Osteoporos Int. 2022 Dec 28. doi: 10.1007/s00198-022-06619.
    >> Share

  186. YANG S, Dong Z, Kan B
    Comments to "No impact of anti-Rank ligand and PTH analogs on cardiovascular risk in postmenopausal osteoporosis: a systematic literature review and meta-analysis".
    Osteoporos Int. 2022 Dec 23. doi: 10.1007/s00198-022-06644.
    >> Share

  187. KOSTEV K, Tanislav C
    Impact of the COVID-19 pandemic on osteoporotic hip fractures among outpatients in Germany.
    Osteoporos Int. 2022 Dec 17:1-2. doi: 10.1007/s00198-022-06641.
    >> Share

  188. YU G, Tong S, Liu J, Wan Y, et al
    A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis.
    Osteoporos Int. 2022 Dec 17. doi: 10.1007/s00198-022-06626.
    >> Share

  189. YE C, Leslie WD
    Fracture risk and assessment in adults with cancer.
    Osteoporos Int. 2022 Dec 13. doi: 10.1007/s00198-022-06631.
    >> Share

  190. RAN S, Zhao MF, Liu BL
    The causal association of sarcopenia with osteoporosis and obesity: a Mendelian randomization analysis.
    Osteoporos Int. 2022 Dec 5. doi: 10.1007/s00198-022-06628.
    >> Share

  191. KARA M, Ozcakar L
    Sarcopenia, osteoporosis, and fractures: what we see mainly depends on how we look?
    Osteoporos Int. 2022 Dec 5. doi: 10.1007/s00198-022-06418.
    >> Share

  192. HARRIS RJ, Parimi N, Cawthon PM, Strotmeyer ES, et al
    Response letter to "sarcopenia, osteoporosis and fractures: what we see".
    Osteoporos Int. 2022 Dec 5. doi: 10.1007/s00198-022-06620.
    >> Share

  193. CHEN PW, Su HY, Tu YK, Wu CH, et al
    Association of bisphosphonates with diabetes risk and glycemic control: a meta-analysis.
    Osteoporos Int. 2022 Dec 5. doi: 10.1007/s00198-022-06616.
    >> Share

  194. AGARWAL AR, Cohen JS, Jorgensen A, Thakkar SC, et al
    Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019.
    Osteoporos Int. 2022 Dec 3. doi: 10.1007/s00198-022-06622.
    >> Share

  195. LANGDAHL B, Hofbauer LC, Ferrari S, Wang Z, et al
    Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
    Osteoporos Int. 2022;33:2527-2536.
    >> Share

  196. HANS D, Shevroja E, McDermott M, Huang S, et al
    Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis.
    Osteoporos Int. 2022;33:2517-2525.
    >> Share

    November 2022
  197. HASSANABADI N, Berger C, Papaioannou A, Cheung AM, et al
    Variation in bone mineral density and fractures over 20 years among Canadians: a comparison of the Canadian Multicenter Osteoporosis Study and the Canadian Longitudinal Study on Aging.
    Osteoporos Int. 2022 Nov 30. doi: 10.1007/s00198-022-06623.
    >> Share

  198. XIAO PL, Lu HD
    Response to: Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated.
    Osteoporos Int. 2022 Nov 29. doi: 10.1007/s00198-022-06603.
    >> Share

  199. WANG YXJ
    Estimation of osteoporosis prevalence among a population is reasonable only after the concerned reference bone mineral density database and cutpoint T-score have been validated.
    Osteoporos Int. 2022 Nov 29. doi: 10.1007/s00198-022-06538.
    >> Share

  200. NG E, Ashkar C, Seeman E, Schneider HG, et al
    A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients.
    Osteoporos Int. 2022 Nov 24. doi: 10.1007/s00198-022-06597.
    >> Share

  201. TARANTINO U, Greggi C, Visconti VV, Cariati I, et al
    Fracture liaison service model: project design and accreditation.
    Osteoporos Int. 2022 Nov 24. doi: 10.1007/s00198-022-06600.
    >> Share

  202. DING BTK, Lim HF, Johari F, Kunnasegaran R, et al
    An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures.
    Osteoporos Int. 2022 Nov 21. doi: 10.1007/s00198-022-06595.
    >> Share

  203. PERIS P, Monegal A, Makitie RE, Guanabens N, et al
    Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis.
    Osteoporos Int. 2022 Nov 18. pii: 10.1007/s00198-022-06609.
    >> Share

  204. GAO SS, Zhao Y
    The effects of beta-carotene on osteoporosis: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2022 Nov 16. pii: 10.1007/s00198-022-06593.
    >> Share

  205. BINKLEY N, Schousboe JT, Lix LM, Morin SN, et al
    Should vertebral fracture assessment be performed in Fracture Liaison Service patients with non-vertebral fracture?
    Osteoporos Int. 2022 Nov 16. pii: 10.1007/s00198-022-06586.
    >> Share

  206. PARASKEVOPOULOS K, Keskinis A, Vasios IS, Makiev KG, et al
    Comparison of various treatment modalities for the management of bone marrow edema syndrome/transient osteoporosis in men and non-pregnant women: a systematic review.
    Osteoporos Int. 2022 Nov 12. pii: 10.1007/s00198-022-06584.
    >> Share

  207. DUARTE MP, Ribeiro HS, Neri SGR, Almeida LS, et al
    Prevalence of low bone mineral density (T-score
    Osteoporos Int. 2022 Nov 12. pii: 10.1007/s00198-022-06598.
    >> Share

  208. JACOBSON BENSKY M, Adler L, Banon T, Gabay L, et al
    Risk of major osteoporotic fractures among ultra-orthodox Jews.
    Osteoporos Int. 2022 Nov 11. pii: 10.1007/s00198-022-06522.
    >> Share

  209. MENGEL E, Tamme R, Remmel L, Purge P, et al
    Pubertal increment in insulin resistance is negatively related to lumbar bone mineral density in 18-year-old males.
    Osteoporos Int. 2022 Nov 11. pii: 10.1007/s00198-022-06591.
    >> Share

  210. HOFFMANN I, Kohl M, von Stengel S, Jakob F, et al
    Exercise and the prevention of major osteoporotic fractures in adults: a systematic review and meta-analysis with special emphasis on intensity progression and study duration.
    Osteoporos Int. 2022 Nov 10. pii: 10.1007/s00198-022-06592.
    >> Share

  211. AALTONEN HL, O'Reilly MK, Linnau KF, Dong Q, et al
    m2ABQ-a proposed refinement of the modified algorithm-based qualitative classification of osteoporotic vertebral fractures.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06546.
    >> Share

  212. PHUNG K, McAdam L, Ma J, McMillan HJ, et al
    Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06578.
    >> Share

  213. DWIVEDI R, Mishra L, Ghobrial H, Abbas H, et al
    Prevalent vertebral fractures in patients admitted with acute hip fracture.
    Osteoporos Int. 2022 Nov 7. pii: 10.1007/s00198-022-06564.
    >> Share

  214. KOH AJ, Nam HK, Michalski MN, Do J, et al
    Anabolic actions of parathyroid hormone in a hypophosphatasia mouse model.
    Osteoporos Int. 2022;33:2423-2433.
    >> Share

  215. SALE JEM, Yang A, Inrig T, Gandhi S, et al
    Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS.
    Osteoporos Int. 2022;33:2435-2440.
    >> Share

    October 2022
  216. KANIS JA, McCloskey EV, Harvey NC, Cooper C, et al
    The need to distinguish intervention thresholds and diagnostic thresholds in the management of osteoporosis.
    Osteoporos Int. 2022 Oct 25. pii: 10.1007/s00198-022-06567.
    >> Share

  217. DE OLIVEIRA RDJ, de Oliveira RG, de Oliveira LC, Santos-Filho SD, et al
    Effectiveness of whole-body vibration on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2022 Oct 25. pii: 10.1007/s00198-022-06556.
    >> Share

  218. KIM J, Ha J, Jeong C, Lee J, et al
    Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study.
    Osteoporos Int. 2022 Oct 18. pii: 10.1007/s00198-022-06571.
    >> Share

  219. POORIRANI S, Taheri SL, Mostafavi SA
    Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis.
    Osteoporos Int. 2022 Oct 15. pii: 10.1007/s00198-022-06543.
    >> Share

  220. MORI S, Hagino H, Sugimoto T, Tanaka S, et al
    Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2022 Oct 14. pii: 10.1007/s00198-022-06570.
    >> Share

  221. LAIRD C, Benson H, Williams KA
    Pharmacist interventions in osteoporosis management: a systematic review.
    Osteoporos Int. 2022 Oct 14. pii: 10.1007/s00198-022-06561.
    >> Share

  222. HUANG YP, Chen LS, Feng SH, Liang YS, et al
    Tea consumption and the risks of osteoporosis and hip fracture: a population-based longitudinal follow-up study.
    Osteoporos Int. 2022 Oct 14. pii: 10.1007/s00198-022-06569.
    >> Share

  223. ZHOU C
    Reply to comments on "Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis".
    Osteoporos Int. 2022 Oct 13. pii: 10.1007/s00198-022-06331.
    >> Share

  224. KHOURI C, Lepelley M, Mallaret M
    Comment on Zhou et al.: Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Oct 13. pii: 10.1007/s00198-022-06507.
    >> Share

  225. KOO HY, Cho EB, Kong SH, Han K, et al
    Fracture risk in Parkinson's disease according to its severity and duration.
    Osteoporos Int. 2022 Oct 7. pii: 10.1007/s00198-022-06562.
    >> Share

  226. TIFTIK T, Kara M, Koyuncu EG, Kaymak B, et al
    The relationship between sarcopenia-related measurements and osteoporosis: The SARCOP study.
    Osteoporos Int. 2022 Oct 4. pii: 10.1007/s00198-022-06563.
    >> Share

    September 2022
  227. HE Y, Chen Y
    The potential mechanism of the microbiota-gut-bone axis in osteoporosis: a review.
    Osteoporos Int. 2022 Sep 28. pii: 10.1007/s00198-022-06557.
    >> Share

  228. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khattak M, et al
    Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 Sep 23. pii: 10.1007/s00198-022-06440.
    >> Share

  229. EBINA K, Etani Y, Tsuboi H, Nagayama Y, et al
    Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis.
    Osteoporos Int. 2022 Sep 6. pii: 10.1007/s00198-022-06545.
    >> Share

    August 2022
  230. MORIN SN, Berger C, Papaioannou A, Cheung AM, et al
    Race/ethnic differences in the prevalence of osteoporosis, falls and fractures: a cross-sectional analysis of the Canadian Longitudinal Study on Aging.
    Osteoporos Int. 2022 Aug 31. pii: 10.1007/s00198-022-06539.
    >> Share

  231. BOKRANTZ T, Manhem K, Lorentzon M, Karlsson M, et al
    The association between peripheral arterial disease and risk for hip fractures in elderly men is not explained by low hip bone mineral density. Results from the MrOS Sweden study.
    Osteoporos Int. 2022 Aug 19. pii: 10.1007/s00198-022-06535.
    >> Share

  232. SUZUKI T, Mizobuchi M, Yoshida S, Terado N, et al
    Romosozumab successfully regulated progressive osteoporosis in a patient with autosomal dominant polycystic kidney disease undergoing hemodialysis.
    Osteoporos Int. 2022 Aug 18. pii: 10.1007/s00198-022-06534.
    >> Share

  233. YANG J, Liao M, Wang Y, Chen L, et al
    Opportunistic osteoporosis screening using chest CT with artificial intelligence.
    Osteoporos Int. 2022 Aug 6. pii: 10.1007/s00198-022-06491.
    >> Share

  234. CHIAPPARELLI E, Okano I, Adl Amini D, Zhu J, et al
    The association between lumbar paraspinal muscle functional cross-sectional area on MRI and regional volumetric bone mineral density measured by quantitative computed tomography.
    Osteoporos Int. 2022 Aug 6. pii: 10.1007/s00198-022-06430.
    >> Share

  235. SHIN JW, He Q, Suk YJ, Kim SH, et al
    Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk.
    Osteoporos Int. 2022 Aug 4. pii: 10.1007/s00198-022-06495.
    >> Share

  236. LU K, Shi Q, Gong YQ, Shao JW, et al
    Predicting the acute-phase response fever risk in bisphosphonate-naive osteoporotic patients receiving their first dose of zoledronate.
    Osteoporos Int. 2022 Aug 3. pii: 10.1007/s00198-022-06493.
    >> Share

  237. LIPPUNER K, Rimmer G, Stuck AK, Schwab P, et al
    Hospitalizations for major osteoporotic fractures in Switzerland: a long-term trend analysis between 1998 and 2018.
    Osteoporos Int. 2022 Aug 2. pii: 10.1007/s00198-022-06481.
    >> Share

  238. COSMAN F, Cooper C, Wang Y, Mitlak B, et al
    Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study.
    Osteoporos Int. 2022;33:1703-1714.
    >> Share

    July 2022
  239. GRIMBLY C, Escagedo PD, Jaremko JL, Bruce A, et al
    Sickle cell bone disease and response to intravenous bisphosphonates in children.
    Osteoporos Int. 2022 Jul 29. pii: 10.1007/s00198-022-06455.
    >> Share

  240. LEBOFF MS, Greenspan SL, Insogna KL, Lewiecki EM, et al
    Correction to: The clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2022 Jul 28. pii: 10.1007/s00198-022-06479.
    >> Share

  241. TARANTINO U, Cariati I, Greggi C, Iundusi R, et al
    Gaps and alternative surgical and non-surgical approaches in the bone fragility management: an updated review.
    Osteoporos Int. 2022 Jul 18. pii: 10.1007/s00198-022-06482.
    >> Share

  242. PUENTE N, Vega AI, Hernandez JL, Fernandez-Luna JL, et al
    An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family.
    Osteoporos Int. 2022 Jul 15. pii: 10.1007/s00198-022-06494.
    >> Share

  243. LORENTZON M, Johansson H, Harvey NC, Liu E, et al
    Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials.
    Osteoporos Int. 2022 Jul 14. pii: 10.1007/s00198-022-06483.
    >> Share

  244. XIAO PL, Fuerwa C, Hsu CJ, Peng R, et al
    Socioeconomic status influences on bone mineral density in American men: findings from NHANES 2011-2020.
    Osteoporos Int. 2022 Jul 14. pii: 10.1007/s00198-022-06498.
    >> Share

  245. FIXEN CW, Fixen DR
    Renal safety of zoledronic acid for osteoporosis in adults 75 years and older.
    Osteoporos Int. 2022 Jul 13. pii: 10.1007/s00198-022-06499.
    >> Share

  246. ZHANG F, Zhou F, Liu H, Zhang X, et al
    Long-term exposure to air pollution might decrease bone mineral density T-score and increase the prevalence of osteoporosis in Hubei province: evidence from China Osteoporosis Prevalence Study.
    Osteoporos Int. 2022 Jul 13. pii: 10.1007/s00198-022-06488.
    >> Share

  247. OSTOVAR A, Mousavi A, Sajjadi-Jazi SM, Rajabi M, et al
    The economic burden of osteoporosis in Iran in 2020.
    Osteoporos Int. 2022 Jul 11. pii: 10.1007/s00198-022-06484.
    >> Share

  248. BELAYA Z, Melnichenko G, Golounina O, Tsoriev T, et al
    Correction: Three-year progress report of Bone Health TeleECHO Moscow: a strategy to improve the care of patients with osteoporosis and other metabolic skeletal diseases in underserved communities of Russia.
    Osteoporos Int. 2022 Jul 7. pii: 10.1007/s00198-022-06469.
    >> Share

  249. FUJIWARA S, Buchanan-Hughes A, Ng A, Page J, et al
    Real-world evaluation of osteoporotic fractures using the Japan Medical Data Vision database.
    Osteoporos Int. 2022 Jul 2. pii: 10.1007/s00198-022-06472.
    >> Share

  250. HA J, Kim J, Jeong C, Lim Y, et al
    Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women.
    Osteoporos Int. 2022;33:1591-1599.
    >> Share

    June 2022
  251. TRAN O, Silverman S, Xu X, Bonafede M, et al
    Correction to: Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women.
    Osteoporos Int. 2022 Jun 29. pii: 10.1007/s00198-022-06410.
    >> Share

  252. PAN B, Cai J, Zhao P, Liu J, et al
    Relationship between prevalence and risk of osteoporosis or osteoporotic fracture with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06459.
    >> Share

  253. MCCLOSKEY EV, Chotiyarnwong P, Harvey NC, Lorentzon M, et al
    Population screening for fracture risk in postmenopausal women - a logical step in reducing the osteoporotic fracture burden?
    Osteoporos Int. 2022 Jun 28. pii: 10.1007/s00198-022-06419.
    >> Share

  254. ABDALBARY M, Sobh M, Elnagar S, Elhadedy MA, et al
    Management of osteoporosis in patients with chronic kidney disease.
    Osteoporos Int. 2022 Jun 24. pii: 10.1007/s00198-022-06462.
    >> Share

  255. BONLOKKE SE, Rand MS, Haddock B, Arup S, et al
    Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Osteoporos Int. 2022 Jun 21. pii: 10.1007/s00198-022-06457.
    >> Share

  256. DUONG LT, Clark S, Pickarski M, Giezek H, et al
    Effects of odanacatib on bone-turnover markers in osteoporotic postmenopausal women: a post hoc analysis of the LOFT study.
    Osteoporos Int. 2022 Jun 17. pii: 10.1007/s00198-022-06406.
    >> Share

  257. ZHANG F, Wang Z, Su H, Zhao H, et al
    Effect of a home-based resistance exercise program in elderly participants with osteoporosis: a randomized controlled trial.
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06456.
    >> Share

  258. TALEVSKI J, Sanders KM, Lal A, Watts JJ, et al
    A micro-costing analysis of post-fracture care pathways: results from the International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS).
    Osteoporos Int. 2022 Jun 15. pii: 10.1007/s00198-022-06460.
    >> Share

  259. BAILEY S, Mhango G, Lin JJ
    The impact of bone mineral density screening on incident fractures and healthcare resource utilization among postmenopausal breast cancer survivors treated with aromatase inhibitors.
    Osteoporos Int. 2022 Jun 14. pii: 10.1007/s00198-022-06458.
    >> Share

  260. PASKINS Z, Babatunde O, Sturrock A, Toh LS, et al
    Supporting patients to get the best from their osteoporosis treatment: a rapid realist review of what works, for whom, and in what circumstance.
    Osteoporos Int. 2022 Jun 11. pii: 10.1007/s00198-022-06453.
    >> Share

  261. XIAO PL, Cui AY, Hsu CJ, Peng R, et al
    Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jun 10. pii: 10.1007/s00198-022-06454.
    >> Share

  262. ROSS BJ, Ross AJ, Lee OC, Waters TL, et al
    Osteoporosis management and secondary fragility fracture rates in patients with multiple sclerosis: a matched cohort study.
    Osteoporos Int. 2022 Jun 7. pii: 10.1007/s00198-022-06451.
    >> Share

  263. GOLD LS, Cody RF Jr, Tan WK, Marcum ZA, et al
    Osteoporosis identification among previously undiagnosed individuals with vertebral fractures.
    Osteoporos Int. 2022 Jun 3. pii: 10.1007/s00198-022-06450.
    >> Share

  264. ALOIA JF, Islam S
    Trabecular bone score in PODA, a Randomized Controlled Trial (RCT) in older African American Women.
    Osteoporos Int. 2022;33:1411-1412.
    >> Share

  265. JACOB JJ, Paul TV
    Romosozumab and cardiovascular safety-should we learn lessons from pioglitazone?
    Osteoporos Int. 2022;33:1397-1399.
    >> Share

  266. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Response to Letter. "Romosozumab and cardiovascular safety- should we learn lessons from Pioglitazone?."
    Osteoporos Int. 2022;33:1401-1402.
    >> Share

  267. COSMAN F, Kendler DL, Langdahl BL, Leder BZ, et al
    Romosozumab and antiresorptive treatment: the importance of treatment sequence.
    Osteoporos Int. 2022;33:1243-1256.
    >> Share

    May 2022
  268. CHOO YW, Mohd Tahir NA, Mohamed Said MS, Li SC, et al
    Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia.
    Osteoporos Int. 2022 May 31. pii: 10.1007/s00198-022-06444.
    >> Share

  269. VANDENPUT L, Johansson H, McCloskey EV, Liu E, et al
    Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan.
    Osteoporos Int. 2022 May 31. pii: 10.1007/s00198-022-06435.
    >> Share

  270. RIVERA-PAREDEZ B, Quezada-Sanchez AD, Robles-Rivera K, Hidalgo-Bravo A, et al
    Dietary inflammatory index and bone mineral density in Mexican population.
    Osteoporos Int. 2022 May 28. pii: 10.1007/s00198-022-06434.
    >> Share

  271. LEE K, Al Jumaily K, Lin M, Siminoski K, et al
    Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing.
    Osteoporos Int. 2022 May 26. pii: 10.1007/s00198-022-06438.
    >> Share

  272. SAHOTA A, Barbary R, Cameron M, Stewart AM, et al
    Safety of zoledronate in older patients at high risk of fracture with reduced renal function.
    Osteoporos Int. 2022 May 23. pii: 10.1007/s00198-022-06427.
    >> Share

  273. BELAYA Z, Melnichenko G, Golounina O, Tsoriev T, et al
    Three-year progress report of Bone Health TeleECHO Moscow: a strategy to improve the care of patients with osteoporosis and other metabolic skeletal diseases in underserved communities of Russia.
    Osteoporos Int. 2022 May 20. pii: 10.1007/s00198-022-06431.
    >> Share

  274. KONG XK, Zhao ZY, Zhang D, Xie R, et al
    Major osteoporosis fracture prediction in type 2 diabetes: a derivation and comparison study.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06425.
    >> Share

  275. TSAKNAKIS K, Jackle K, Luders KA, Lorenz HM, et al
    Reduced bone mineral density in adolescents with Duchenne Muscular Dystrophy (DMD) and scoliosis.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06416.
    >> Share

  276. ZHAO C, Liu X, Wang Y, Guo J, et al
    The effects of biomechanical factors on adjacent vertebral compression fractures after percutaneous kyphoplasty: a propensity score matching analysis.
    Osteoporos Int. 2022 May 18. pii: 10.1007/s00198-022-06428.
    >> Share

  277. KONSTANTELOS N, Rzepka AM, Burden AM, Cheung AM, et al
    Fracture definitions in observational osteoporosis drug effects studies that leverage healthcare administrative (claims) data: a scoping review.
    Osteoporos Int. 2022 May 17. pii: 10.1007/s00198-022-06395.
    >> Share

  278. BRUELL S, Nicholls KM, Hewitson TD, Talbot AS, et al
    Reduced hip bone mineral density is associated with high levels of calciprotein particles in patients with Fabry disease.
    Osteoporos Int. 2022 May 16. pii: 10.1007/s00198-022-06420.
    >> Share

  279. HAYDEN AC, Binkley N, Krueger D, Bernatz JT, et al
    Effect of degeneration on bone mineral density, trabecular bone score and CT Hounsfield unit measurements in a spine surgery patient population.
    Osteoporos Int. 2022 May 12. pii: 10.1007/s00198-022-06407.
    >> Share

  280. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khatak M, et al
    Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 May 3. pii: 10.1007/s00198-022-06323.
    >> Share

    April 2022
  281. LEBOFF MS, Greenspan SL, Insogna KL, Lewiecki EM, et al
    The clinician's guide to prevention and treatment of osteoporosis.
    Osteoporos Int. 2022 Apr 28. pii: 10.1007/s00198-021-05900.
    >> Share

  282. CARBALLIDO-GAMIO J, Posadzy M, Wu PH, Kenny K, et al
    People living with HIV have low trabecular bone mineral density, high bone marrow adiposity, and poor trabecular bone microarchitecture at the proximal femur.
    Osteoporos Int. 2022 Apr 27. pii: 10.1007/s00198-022-06405.
    >> Share

  283. ZHANG X, Xu Y, Li F, Chen M, et al
    Associations between bone mineral density and subclinical peripheral arterial disease in elderly men with type 2 diabetes mellitus.
    Osteoporos Int. 2022 Apr 22. pii: 10.1007/s00198-022-06404.
    >> Share

  284. JOHANSSON L, Johansson H, Axelsson KF, Litsne H, et al
    Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX.
    Osteoporos Int. 2022 Apr 22. pii: 10.1007/s00198-022-06387.
    >> Share

  285. ZENG X, Su Y, Tan A, Zou L, et al
    The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Apr 15. pii: 10.1007/s00198-022-06399.
    >> Share

  286. HILIGSMANN M, Li N, Cooper C, Reginster JY, et al
    Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement.
    Osteoporos Int. 2022 Apr 12. pii: 10.1007/s00198-022-06400.
    >> Share

  287. XU W, Wu W, Yang S, Chen T, et al
    Correction to: Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
    Osteoporos Int. 2022 Apr 6. pii: 10.1007/s00198-022-06397.
    >> Share

  288. KIM D, Pirshahid AA, Li Y, Varghese T, et al
    Prevalence of osteoporosis in osteoarthritis: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Apr 5. pii: 10.1007/s00198-022-06376.
    >> Share

  289. HARRIS RJ, Parimi N, Cawthon PM, Strotmeyer ES, et al
    Associations of components of sarcopenia with risk of fracture in the Osteoporotic Fractures in Men (MrOS) study.
    Osteoporos Int. 2022 Apr 5. pii: 10.1007/s00198-022-06390.
    >> Share

  290. DU EZ, Wang YXJ
    CT detects more osteoporotic endplate depressions than radiograph: a descriptive comparison of 76 vertebrae.
    Osteoporos Int. 2022 Apr 4. pii: 10.1007/s00198-022-06391.
    >> Share

  291. MINISOLA S, Cipriani C, Vigna E, Sonato C, et al
    COVID pandemic and denosumab adherence.
    Osteoporos Int. 2022;33:943-944.
    >> Share

  292. EBINA K, Etani Y, Tsuboi H, Nagayama Y, et al
    Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis.
    Osteoporos Int. 2022 Apr 1. pii: 10.1007/s00198-022-06386.
    >> Share


  293. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Author Index.
    Osteoporos Int. 2022;33.
    >> Share


  294. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts.
    Osteoporos Int. 2022;33.
    >> Share


  295. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Oral Communication Abstracts.
    Osteoporos Int. 2022;33.
    >> Share


  296. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Symposium Abstract.
    Osteoporos Int. 2022;33.
    >> Share


  297. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference: Speaker Abstracts.
    Osteoporos Int. 2022;33.
    >> Share


  298. IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference.
    Osteoporos Int. 2022;33.
    >> Share

    March 2022
  299. GONZALEZ-QUEVEDO D, Perez-Del-Rio V, Moriel-Garceso D, Fernandez-Arroyabe N, et al
    A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study.
    Osteoporos Int. 2022 Mar 31. pii: 10.1007/s00198-022-06298.
    >> Share

  300. LENTLE BC, Prior JC
    Osteoporotic vertebral fracture (OVF): diagnosis requires an informed observer.
    Osteoporos Int. 2022 Mar 30. pii: 10.1007/s00198-021-06287.
    >> Share

  301. WANG YXJ
    Osteoporotic vertebral endplate and/or cortex fracture is not always radiographically detectable.
    Osteoporos Int. 2022 Mar 30. pii: 10.1007/s00198-021-06254.
    >> Share

  302. XU WX, Wu W, Yang S, Chen T, et al
    Risk of osteoporosis and fracture after hysterectomies without oophorectomies: a systematic review and pooled analysis.
    Osteoporos Int. 2022 Mar 29. pii: 10.1007/s00198-022-06383.
    >> Share

  303. AKESSON KE, Ganda K, Deignan C, Oates MK, et al
    Post-fracture care programs for prevention of subsequent fragility fractures: a literature assessment of current trends.
    Osteoporos Int. 2022 Mar 24. pii: 10.1007/s00198-022-06358.
    >> Share

  304. SCHOEB M, Winter EM, Malgo F, Schipper IB, et al
    Bone material strength index as measured by in vivo impact microindentation is normal in subjects with high-energy trauma fractures.
    Osteoporos Int. 2022 Mar 21. pii: 10.1007/s00198-022-06368.
    >> Share

  305. KAST S, Shojaa M, Kohl M, von Stengel S, et al
    Effects of different exercise intensity on bone mineral density in adults: a comparative systematic review and meta-analysis.
    Osteoporos Int. 2022 Mar 18. pii: 10.1007/s00198-022-06329.
    >> Share

  306. JAVAID MK, Harvey NC, McCloskey EV, Kanis JA, et al
    Assessment and management of imminent fracture risk in the setting of the fracture liaison service.
    Osteoporos Int. 2022 Mar 14. pii: 10.1007/s00198-021-06284.
    >> Share

  307. HA J, Baek KH
    Correction to: Response to letter, re. "Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data".
    Osteoporos Int. 2022 Mar 11. pii: 10.1007/s00198-022-06373.
    >> Share

  308. TUCK SP, Datta HK
    Letter of response to Professor Dalgleish regarding our paper Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2022 Mar 2. pii: 10.1007/s00198-022-06332.
    >> Share

  309. DALGLEISH R
    Re: Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2022 Mar 2. pii: 10.1007/s00198-022-06334.
    >> Share

    February 2022
  310. SANCHEZ-TRIGO H, Rittweger J, Sanudo B
    Effects of non-supervised exercise interventions on bone mineral density in adult women: a systematic review and metaanalysis.
    Osteoporos Int. 2022 Feb 26. pii: 10.1007/s00198-022-06357.
    >> Share

  311. OKUDA R, Osaki M, Saeki Y, Okano T, et al
    Effect of coordinator-based osteoporosis intervention on quality of life in patients with fragility fractures: a prospective randomized trial.
    Osteoporos Int. 2022 Feb 23. pii: 10.1007/s00198-021-06279.
    >> Share

  312. BASTOUNIS A, Langley T, Davis S, Paskins Z, et al
    Comparing medication adherence in patients receiving bisphosphonates for preventing fragility fractures: a comprehensive systematic review and network meta-analysis.
    Osteoporos Int. 2022 Feb 21. pii: 10.1007/s00198-022-06350.
    >> Share

  313. OTHMAN M, Menon VK
    The prevalence of Schmorl's nodes in osteoporotic vs normal patients: a Middle Eastern population study.
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06316.
    >> Share

  314. LESLIE WD, Moller S, Skjodt MK, Yan L, et al
    FREM predicts 10-year incident fracture risk independent of FRAX(R) probability: a registry-based cohort study.
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06349.
    >> Share

  315. JEONGHOON H, Ki-Hyun B
    Response to letter, re. "Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data".
    Osteoporos Int. 2022 Feb 17. pii: 10.1007/s00198-022-06336.
    >> Share

  316. GEBRE AK, Prince RL, Schousboe JT, Kiel DP, et al
    Calcaneal quantitative ultrasound is associated with all-cause and cardiovascular disease mortality independent of hip bone mineral density.
    Osteoporos Int. 2022 Feb 11. pii: 10.1007/s00198-022-06317.
    >> Share

  317. KHALID S, Calderon-Larranaga S, Sami A, Hawley S, et al
    Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
    Osteoporos Int. 2022 Feb 9. pii: 10.1007/s00198-021-06262.
    >> Share

  318. FLEHR A, Kallgard J, Alven J, Lagerstrand K, et al
    Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography.
    Osteoporos Int. 2022 Feb 3. pii: 10.1007/s00198-021-06224.
    >> Share

  319. GAGGIANO C, Bardelli M, Tarsia M, Gentileschi S, et al
    Neridronate for transient osteoporosis of the hip in a child.
    Osteoporos Int. 2022 Feb 1. pii: 10.1007/s00198-022-06324.
    >> Share

  320. ABDEL-HAMID MS, Elhossini RM, Otaify GA, Abdel-Ghafar SF, et al
    Osteoporosis-pseudoglioma syndrome in four new patients: identification of two novel LRP5 variants and insights on patients' management using bisphosphonates therapy.
    Osteoporos Int. 2022 Feb 1. pii: 10.1007/s00198-022-06313.
    >> Share

  321. CANOY D, Harvey NC, Prieto-Alhambra D, Cooper C, et al
    Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions.
    Osteoporos Int. 2022;33:315-326.
    >> Share

    January 2022
  322. GOSSIEL F, Ugur A, Peel NFA, Walsh JS, et al
    The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis.
    Osteoporos Int. 2022 Jan 31. pii: 10.1007/s00198-022-06311.
    >> Share

  323. ASAHI R, Nakamura Y, Kanai M, Watanabe K, et al
    Association with sagittal alignment and osteoporosis-related fractures in outpatient women with osteoporosis.
    Osteoporos Int. 2022 Jan 29. pii: 10.1007/s00198-021-06282.
    >> Share

  324. BEAUDART C, Boonen A, Li N, Bours S, et al
    Patient preferences for lifestyle behaviours in osteoporotic fracture prevention: a cross-European discrete choice experiment.
    Osteoporos Int. 2022 Jan 26. pii: 10.1007/s00198-022-06310.
    >> Share

  325. STARUP-LINDE J, Langdahl B, Vestergaard P, Harslof T, et al
    Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates-a real-world cohort study.
    Osteoporos Int. 2022 Jan 26. pii: 10.1007/s00198-022-06315.
    >> Share

  326. GUPTA A, Cha T, Schwab J, Fogel H, et al
    Response to Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06243.
    >> Share

  327. HONG FX, Xue FS, Hu B, Tian T, et al
    Assessing impacts of gender on adverse postoperative outcomes in patients undergoing osteoporotic vertebral compression fracture surgery.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-05992.
    >> Share

  328. WAN Y, Zeng F, Tan H, Lu Y, et al
    Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06268.
    >> Share

  329. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Effect of the duration of previous osteoporosis treatment on the effect of romosozumab treatment.
    Osteoporos Int. 2022 Jan 21. pii: 10.1007/s00198-021-06261.
    >> Share

  330. PINTO D, Alshahrani M, Chapurlat R, Chevalley T, et al
    The global approach to rehabilitation following an osteoporotic fragility fracture: A review of the rehabilitation working group of the International Osteoporosis Foundation (IOF) committee of scientific advisors.
    Osteoporos Int. 2022 Jan 20. pii: 10.1007/s00198-021-06240.
    >> Share

  331. SCHOUSBOE JT, Binkley N, Leslie WD
    Accurate estimation of vertebral fracture prevalence on lateral spine imaging requires use of validated ascertainment methods.
    Osteoporos Int. 2022 Jan 16. pii: 10.1007/s00198-021-06275.
    >> Share

  332. LAI EC, Lin TC, Lange JL, Chen L, et al
    Effectiveness of denosumab for fracture prevention in real-world postmenopausal women with osteoporosis: a retrospective cohort study.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-021-06291.
    >> Share

  333. PATEL R, Shen J, Nichols JF, Schousboe JT, et al
    Trabecular bone score and its association with Cobb angle kyphosis in older men: a cross-sectional study for the Osteoporotic Fractures in Men (MrOS) Study.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-021-06267.
    >> Share

  334. KIMMEL DB, Vennin S, Desyatova A, Turner JA, et al
    Bone architecture, bone material properties, and bone turnover in non-osteoporotic post-menopausal women with fragility fracture.
    Osteoporos Int. 2022 Jan 15. pii: 10.1007/s00198-022-06308.
    >> Share

  335. STROM RONNQUIST S, Viberg B, Kristensen MT, Palm H, et al
    Frailty and osteoporosis in patients with hip fractures under the age of 60-a prospective cohort of 218 individuals.
    Osteoporos Int. 2022 Jan 14. pii: 10.1007/s00198-021-06281.
    >> Share

  336. IIDA H, Sakai Y, Seki T, Watanabe T, et al
    Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture.
    Osteoporos Int. 2022 Jan 13. pii: 10.1007/s00198-021-06264.
    >> Share

  337. IKI M, Fujimori K, Nakatoh S, Tamaki J, et al
    Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study.
    Osteoporos Int. 2022 Jan 13. pii: 10.1007/s00198-021-06265.
    >> Share

  338. LIANG YS, Yeh KC, Pan SL
    Osteoporosis and the long-term risk of peripheral artery disease: a population-based longitudinal follow-up study in Taiwan.
    Osteoporos Int. 2022 Jan 12. pii: 10.1007/s00198-022-06305.
    >> Share

  339. BERNARDES M, Monteiro R, Martins MJ
    Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteoporos Int. 2021;32(7):1313-20.
    Osteoporos Int. 2022 Jan 12. pii: 10.1007/s00198-021-06272.
    >> Share

  340. SHABANI F, Tsinaslanidis G, Thimmaiah R, Khatak M, et al
    Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care.
    Osteoporos Int. 2022 Jan 8. pii: 10.1007/s00198-021-06249.
    >> Share

  341. CLAUSEN A, Moller S, Skjodt MK, Bech BH, et al
    Evaluating the performance of the Charlson Comorbidity Index (CCI) in fracture risk prediction and developing a new Charlson Fracture Index (CFI): a register-based cohort study.
    Osteoporos Int. 2022 Jan 6. pii: 10.1007/s00198-021-06293.
    >> Share

  342. SAAD RK, Ghezzawi M, Habli D, Alami RS, et al
    Fracture risk following bariatric surgery: a systematic review and meta-analysis.
    Osteoporos Int. 2022 Jan 5. pii: 10.1007/s00198-021-06206.
    >> Share

  343. BERMAN NK, Honig S, Cronstein BN, Pillinger MH, et al
    The effects of caffeine on bone mineral density and fracture risk.
    Osteoporos Int. 2022 Jan 4. pii: 10.1007/s00198-021-05972.
    >> Share

  344. DOCKERY F, Glynn A, Franks K, Carey JJ, et al
    Fracture liaison services in Ireland-how do we compare to international standards?
    Osteoporos Int. 2022 Jan 4. pii: 10.1007/s00198-021-06251.
    >> Share

  345. PARK SY, Kim J, Chung HY
    Denosumab-induced hypocalcemia in a patient with hyperthyroidism: a case report.
    Osteoporos Int. 2022;33:305-308.
    >> Share

    December 2021
  346. FAN Y, Ni S, Zhang H
    Association between Healthy Eating Index-2015 total and component food scores with osteoporosis in middle-aged and older Americans: a cross-sectional study with U.S. National Health and Nutrition Examination Survey.
    Osteoporos Int. 2021 Dec 2. pii: 10.1007/s00198-021-06247.
    >> Share

  347. NASSAR K, Janani S
    Diffuse adverse cutaneous reactions induced by zoledronic acid administration: a case report : Eruptions cutanees diffuses induites par l'administration de l'acide zoledronique.
    Osteoporos Int. 2021;32:2583-2586.
    >> Share

  348. BOCKER W, Doobaree IU, Khachatryan A, Dornstauder E, et al
    Correction to: Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
    Osteoporos Int. 2021 Dec 1. pii: 10.1007/s00198-021-06244.
    >> Share

  349. CURTIN L, Conway MC, Kilbane MT, McKenna MJ, et al
    No effect of maternal calcium intake and bone resorption during pregnancy on offspring bone mineral density at age 5 years.
    Osteoporos Int. 2021 Dec 1. pii: 10.1007/s00198-021-06250.
    >> Share


  350. World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Author Index.
    Osteoporos Int. 2021;32.
    >> Share


  351. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Poster Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  352. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Satellite Sponsored Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  353. World Congress on Osteoporosis, Osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  354. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Committee of Scientific Advisory Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  355. World congress on osteoporosis, osteoarthritis and musculoskeletal diseases (WCO-IOF-ESCEO 2021): Committee of National Societies Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  356. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Meet-The-Experts Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  357. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ISGE-ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  358. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ROS-IOF-ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  359. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): SICOT-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  360. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  361. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  362. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO-WHO CC Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  363. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  364. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO Symposium Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  365. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Oral Communication Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  366. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Plenary Lecture Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  367. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Educational Lectures Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  368. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Special Lecture Abstracts.
    Osteoporos Int. 2021;32.
    >> Share


  369. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021).
    Osteoporos Int. 2021;32.
    >> Share

    November 2021
  370. AGARWAL A, Leslie WD, Nguyen TV, Morin SN, et al
    Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study.
    Osteoporos Int. 2021 Nov 28. pii: 10.1007/s00198-021-06252.
    >> Share

  371. AGARWAL G, Milan C, Mohsin Z, Mahoney S, et al
    Multiple myeloma screening within a fracture liaison service (FLS).
    Osteoporos Int. 2021 Nov 26. pii: 10.1007/s00198-021-06233.
    >> Share

  372. HORII C, Iidaka T, Muraki S, Oka H, et al
    The cumulative incidence of and risk factors for morphometric severe vertebral fractures in Japanese men and women: the ROAD study third and fourth surveys.
    Osteoporos Int. 2021 Nov 19. pii: 10.1007/s00198-021-06143.
    >> Share

  373. KADRI A, Binkley N, Hernando D, Anderson PA, et al
    Opportunistic Use of Lumbar Magnetic Resonance Imaging for Osteoporosis Screening.
    Osteoporos Int. 2021 Nov 13. pii: 10.1007/s00198-021-06129.
    >> Share

  374. RUBAEK M, Hitz MF, Holmberg T, Schonwandt BMT, et al
    Effectiveness of patient education for patients with osteoporosis: a systematic review.
    Osteoporos Int. 2021 Nov 12. pii: 10.1007/s00198-021-06226.
    >> Share

  375. LIU Z, Zhang X, Liu H, Wang D, et al
    A nomogram for short-term recurrent pain after percutaneous vertebroplasty for osteoporotic vertebral compression fractures.
    Osteoporos Int. 2021 Nov 11. pii: 10.1007/s00198-021-06232.
    >> Share

  376. DEMINGER A, Klingberg E, Lorentzon M, Hedberg M, et al
    Correction to: Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
    Osteoporos Int. 2021 Nov 2. pii: 10.1007/s00198-021-06156.
    >> Share

    October 2021
  377. SAITO M, Moore-Lotridge SN, Uppuganti S, Egawa S, et al
    Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair.
    Osteoporos Int. 2021 Oct 31. pii: 10.1007/s00198-021-06208.
    >> Share

  378. THARABENJASIN P, Pabalan N, Jarjanazi H, Jinawath N, et al
    Associations of osteoprotegerin (OPG) TNFRSF11B gene polymorphisms with risk of fractures in older adult populations: meta-analysis of genetic and genome-wide association studies.
    Osteoporos Int. 2021 Oct 30. pii: 10.1007/s00198-021-06161.
    >> Share

  379. ADAMS AL, Ryan DS, Li BH, Williams SA, et al
    Outcomes post fragility fracture among members of an integrated healthcare organization.
    Osteoporos Int. 2021 Oct 23. pii: 10.1007/s00198-021-06205.
    >> Share

  380. PRIOR JC, Oei EHG, Brown JP, Oei L, et al
    Where's the break? Critique of radiographic vertebral fracture diagnostic methods.
    Osteoporos Int. 2021 Oct 21. pii: 10.1007/s00198-021-06207.
    >> Share

  381. CHEN T, Jiang R, Jiang L
    Comment on "Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies".
    Osteoporos Int. 2021 Oct 21. pii: 10.1007/s00198-021-06217.
    >> Share

  382. ASPDEN RM
    RE: Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans : F. Jazinizadeh, J.D. Adachi & C.E. Quenneville. Osteoporosis International volume 31, pages 1925-1933 (2020).
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06096.
    >> Share

  383. GOETZ TG, Nair N, Shiau S, Recker RR, et al
    In premenopausal women with idiopathic osteoporosis, lower bone formation rate is associated with higher body fat and higher IGF-1.
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06196.
    >> Share

  384. JAZINIZADEH F, Adachi J, Quenneville C
    Response to Letter from Prof Aspen, re. "Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans".
    Osteoporos Int. 2021 Oct 19. pii: 10.1007/s00198-021-06192.
    >> Share

  385. SCHINI M, Peel N, Toronjo-Urquiza L, Thomas E, et al
    Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis.
    Osteoporos Int. 2021 Oct 15. pii: 10.1007/s00198-021-06160.
    >> Share

  386. LOFFLER MT, Kallweit M, Niederreiter E, Baum T, et al
    Epidemiology and reporting of osteoporotic vertebral fractures in patients with long-term hospital records based on routine clinical CT imaging.
    Osteoporos Int. 2021 Oct 14. pii: 10.1007/s00198-021-06169.
    >> Share

  387. YAZDANPANAH Z, Beigrezaei S, Mohseni-Takalloo S, Soltani S, et al
    Does exercise affect bone mineral density and content when added to a calorie-restricted diet? A systematic review and meta-analysis of controlled clinical trials.
    Osteoporos Int. 2021 Oct 13. pii: 10.1007/s00198-021-06187.
    >> Share

  388. CHALITSIOS CV, Shaw DE, McKeever TM
    Risk of subtrochanteric and femoral shaft fractures due to bisphosphonate therapy in asthma: a population-based nested case-control study.
    Osteoporos Int. 2021 Oct 11. pii: 10.1007/s00198-021-06197.
    >> Share

  389. KUO DP, Chiu YW, Chen PT, Tsai YJ, et al
    Associations between body composition and vertebral fracture risk in postmenopausal women.
    Osteoporos Int. 2021 Oct 9. pii: 10.1007/s00198-021-06178.
    >> Share

  390. MUSCHITZ C, Hummer M, Grillari J, Hlava A, et al
    Epidemiology and economic burden of fragility fractures in Austria.
    Osteoporos Int. 2021 Oct 8. pii: 10.1007/s00198-021-06152.
    >> Share

  391. SAFIPOUR Z, van der Zanden R, van den Bergh J, Janssen P, et al
    The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis.
    Osteoporos Int. 2021 Oct 3. pii: 10.1007/s00198-021-06101.
    >> Share

  392. MOLLER S, Skjodt MK, Yan L, Abrahamsen B, et al
    Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).
    Osteoporos Int. 2021 Oct 1. pii: 10.1007/s00198-021-06165.
    >> Share

    September 2021
  393. LESLIE WD, Yan L, Lix LM, Morin SN, et al
    Time dependency in early major osteoporotic and hip re-fractures in women and men aged 50 years and older: a population-based observational study.
    Osteoporos Int. 2021 Sep 25. pii: 10.1007/s00198-021-06166.
    >> Share

  394. BEAUDART C, Hiligsmann M, Li N, Lewiecki EM, et al
    Effective communication regarding risk of fracture for individuals at risk of fragility fracture: a scoping review.
    Osteoporos Int. 2021 Sep 24. pii: 10.1007/s00198-021-06151.
    >> Share

  395. GASSERT FT, Kufner A, Gassert FG, Leonhardt Y, et al
    MR-based proton density fat fraction (PDFF) of the vertebral bone marrow differentiates between patients with and without osteoporotic vertebral fractures.
    Osteoporos Int. 2021 Sep 18. pii: 10.1007/s00198-021-06147.
    >> Share

  396. WALTMAN N, Kupzyk KA, Flores LE, Mack LR, et al
    Bone-loading exercises versus risedronate for the prevention of osteoporosis in postmenopausal women with low bone mass: a randomized controlled trial.
    Osteoporos Int. 2021 Sep 14. pii: 10.1007/s00198-021-06083.
    >> Share

  397. GONG Z, Da W, Tian Y, Zhao R, et al
    Exogenous melatonin prevents type 1 diabetes mellitus-induced bone loss, probably by inhibiting senescence.
    Osteoporos Int. 2021 Sep 14. pii: 10.1007/s00198-021-06061.
    >> Share

  398. NAYAK S, Greenspan SL
    Cost-effectiveness of 3 versus 6 years of zoledronic acid treatment before bisphosphonate holiday for women with osteoporosis.
    Osteoporos Int. 2021 Sep 13. pii: 10.1007/s00198-021-06010.
    >> Share

  399. COLON-EMERIC CS, Lee RH
    Bisphosphonate holidays: using cost-effectiveness analysis for the "yes, but" questions.
    Osteoporos Int. 2021 Sep 13. pii: 10.1007/s00198-021-06064.
    >> Share

  400. BLAKER K, Wijewardene A, White E, Stokes G, et al
    Electronic search programs are effective in identifying patients with minimal trauma fractures.
    Osteoporos Int. 2021 Sep 12. pii: 10.1007/s00198-021-06105.
    >> Share

  401. LIU J, Gong T, Xu X, Fox KM, et al
    Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries.
    Osteoporos Int. 2021 Sep 10. pii: 10.1007/s00198-021-06084.
    >> Share

  402. LARSSON BAM, Johansson L, Mellstrom D, Johansson H, et al
    One leg standing time predicts fracture risk in older women independent of clinical risk factors and BMD.
    Osteoporos Int. 2021 Sep 8. pii: 10.1007/s00198-021-06039.
    >> Share

  403. THOMASIUS F, Palacios S, Alam A, Boolell M, et al
    Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis.
    Osteoporos Int. 2021 Sep 6. pii: 10.1007/s00198-021-06108.
    >> Share

  404. BLAND VL, Klimentidis YC, Bea JW, Roe DJ, et al
    Cross-sectional associations between adipose tissue depots and areal bone mineral density in the UK Biobank imaging study.
    Osteoporos Int. 2021 Sep 6. pii: 10.1007/s00198-021-06140.
    >> Share

  405. NIZNIK JD, Aspinall SL, Hanson LC, Gilliam MA, et al
    Patterns of oral bisphosphonate deprescribing in older nursing home residents with dementia.
    Osteoporos Int. 2021 Sep 4. pii: 10.1007/s00198-021-06141.
    >> Share

  406. PARK JH, Cho S, Kim SJ, Jeong TD, et al
    Serum biomarkers for bisphosphonate-related osteonecrosis of the jaw: a prospective clinical study.
    Osteoporos Int. 2021 Sep 2. pii: 10.1007/s00198-021-06137.
    >> Share

    August 2021
  407. VARENNA M, Crotti C, Bonati MT, Zucchi F, et al
    A novel mutation in collagen gene COL1A2 associated with transient regional osteoporosis.
    Osteoporos Int. 2021 Aug 31. pii: 10.1007/s00198-021-06135.
    >> Share

  408. HAGINO H, Sugimoto T, Tanaka S, Sasaki K, et al
    Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05.
    Osteoporos Int. 2021 Aug 27. pii: 10.1007/s00198-021-06066.
    >> Share

  409. SU S, He N, Men P, Song C, et al
    Correction to: The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2021 Aug 27. pii: 10.1007/s00198-021-06053.
    >> Share

  410. SINGH S, Dutta S, Khasbage S, Kumar T, et al
    A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis.
    Osteoporos Int. 2021 Aug 25. pii: 10.1007/s00198-021-06095.
    >> Share

  411. BOSCHITSCH E, Naegele O, Klinger A, Brix-Samoylenko H, et al
    Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis.
    Osteoporos Int. 2021 Aug 25. pii: 10.1007/s00198-021-06102.
    >> Share

  412. CHANDRAN M, Hao Y, Kwee AK, Cheen MHH, et al
    Adherence to dosing schedule of denosumab therapy for osteoporosis during COVID-19 lockdown: an electronic medical record and pharmacy claims database study from Asia.
    Osteoporos Int. 2021 Aug 21. pii: 10.1007/s00198-021-06085.
    >> Share

  413. SEAMAN AT, Steffen MJA, Van Tiem JM, Wardyn S, et al
    Cultivating across "pockets of excellence": challenges to sustaining efforts to improve osteoporosis care.
    Osteoporos Int. 2021 Aug 19. pii: 10.1007/s00198-021-06098.
    >> Share

  414. VENDRAMI C, Marques-Vidal P, Gonzalez Rodriguez E, Hans D, et al
    Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort.
    Osteoporos Int. 2021 Aug 19. pii: 10.1007/s00198-021-06081.
    >> Share

  415. ATMACA A, Demirci I, Haymana C, Tasci I, et al
    No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study.
    Osteoporos Int. 2021 Aug 17. pii: 10.1007/s00198-021-06067.
    >> Share

  416. KHALID S, Reyes C, Ernst M, Delmestri A, et al
    One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data.
    Osteoporos Int. 2021 Aug 15. pii: 10.1007/s00198-021-06077.
    >> Share

  417. ZHANG Y, Tian Z, Ye S, Mu Q, et al
    Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Aug 12. pii: 10.1007/s00198-021-06070.
    >> Share

  418. BAJPAI RC
    Letter to the Editor about the article "C-reactive protein and fracture risk: an updated systematic review and meta-analysis of cohort studies through the use of both frequentist and Bayesian approaches".
    Osteoporos Int. 2021 Aug 12. pii: 10.1007/s00198-020-05750.
    >> Share

  419. SCHEMITSCH E, Adachi JD, Brown JP, Tarride JE, et al
    Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients.
    Osteoporos Int. 2021 Aug 11. pii: 10.1007/s00198-021-06080.
    >> Share

  420. SOLLING AS, Harslof T, Bruun NH, Langdahl B, et al
    The predictive value of bone turnover markers during discontinuation of alendronate: the PROSA study.
    Osteoporos Int. 2021;32:1557-1566.
    >> Share

    July 2021
  421. HA J, Jeong C, Han KD, Lim Y, et al
    Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data.
    Osteoporos Int. 2021 Jul 31. pii: 10.1007/s00198-021-06032.
    >> Share

  422. BOCKER W, Doobare IU, Khachatryan A, Dornstauder E, et al
    Fractures in untreated patients with osteoporosis in Germany: an InGef healthcare insurance database analysis.
    Osteoporos Int. 2021 Jul 15. pii: 10.1007/s00198-021-06051.
    >> Share

  423. ADAMI G, Cattani G, Rossini M, Viapiana O, et al
    Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study.
    Osteoporos Int. 2021 Jul 15. pii: 10.1007/s00198-021-06060.
    >> Share

  424. IBRAHIMAGIC OC, Vujadinovic A, Ercegovic Z, Kunic S, et al
    Retraction Note to: Comment on an article: "Osteoporosis in the age of COVID-19 patients".
    Osteoporos Int. 2021 Jul 14. pii: 10.1007/s00198-021-06031.
    >> Share

  425. DEMINGER A, Klingberg E, Lorentzon M, Hedberg M, et al
    Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.
    Osteoporos Int. 2021 Jul 14. pii: 10.1007/s00198-021-06049.
    >> Share

  426. TALEVSKI J, Sanders KM, Watts JJ, Nicholson GC, et al
    Sex differences in recovery of quality of life 12 months post-fracture in community-dwelling older adults: analyses of the Australian arm of the International Costs and Utilities Related to Osteoporotic Fractures Study (AusICUROS).
    Osteoporos Int. 2021 Jul 8. pii: 10.1007/s00198-021-06058.
    >> Share

  427. HAMED K, Roaldsen KS, Halvarsson A
    "Fear of falling serves as protection and signifies potential danger": a qualitative study to conceptualise the phrase "fear of falling" in women with osteoporosis.
    Osteoporos Int. 2021 Jul 7. pii: 10.1007/s00198-021-06047.
    >> Share

  428. SALE JEM, Yang A, Elliot-Gibson V, Jain R, et al
    Patients 80 + have similar medication initiation rates to those aged 50-79 in Ontario FLS.
    Osteoporos Int. 2021;32:1405-1411.
    >> Share

    June 2021
  429. MORIN SN, Yan L, Lix LM, Leslie WD, et al
    Long-term risk of subsequent major osteoporotic fracture and hip fracture in men and women: a population-based observational study with a 25-year follow-up.
    Osteoporos Int. 2021 Jun 24. pii: 10.1007/s00198-021-06028.
    >> Share

  430. ZHU M, Yin P, Hu F, Jiang J, et al
    Integrating genome-wide association and transcriptome prediction model identifies novel target genes for osteoporosis.
    Osteoporos Int. 2021 Jun 17. pii: 10.1007/s00198-021-06024.
    >> Share

  431. EVENEPOEL P, Cunningham J, Ferrari S, Haarhaus M, et al
    Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism.
    Osteoporos Int. 2021 Jun 15. pii: 10.1007/s00198-021-05975.
    >> Share

  432. SINGER AJ, Liu J, Yan H, Stad RK, et al
    Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage.
    Osteoporos Int. 2021 Jun 7. pii: 10.1007/s00198-021-05951.
    >> Share

    May 2021
  433. CHANDRAN M, Mitchell PJ, Amphansap T, Bhadada SK, et al
    Publisher Correction to: Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.
    Osteoporos Int. 2021 May 27. pii: 10.1007/s00198-021-05953.
    >> Share

  434. STUMPF U, Kraus M, Hadji P
    Influence of denosumab on bone mineral density in a severe case of pregnancy-associated osteoporosis.
    Osteoporos Int. 2021 May 26. pii: 10.1007/s00198-021-06008.
    >> Share

  435. IKI M, Winzenrieth R, Tamaki J, Sato Y, et al
    Predictive ability of novel volumetric and geometric indices derived from dual-energy X-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral density: the Japanese Population-based Osteoporosis
    Osteoporos Int. 2021 May 26. pii: 10.1007/s00198-021-06013.
    >> Share

  436. PAL R, Bhadada SK, Mukherjee S, Banerjee M, et al
    Fracture risk in hypoparathyroidism: a systematic review and meta-analysis.
    Osteoporos Int. 2021 May 22. pii: 10.1007/s00198-021-05966.
    >> Share

  437. VAN DEN BERGH JP, Szulc P, Cheung AM, Bouxsein M, et al
    The clinical application of high-resolution peripheral computed tomography (HR-pQCT) in adults: state of the art and future directions.
    Osteoporos Int. 2021 May 22. pii: 10.1007/s00198-021-05999.
    >> Share

  438. CHEVALLEY T, Brandi ML, Cavalier E, Harvey NC, et al
    How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?
    Osteoporos Int. 2021 May 20. pii: 10.1007/s00198-021-05957.
    >> Share

  439. SVENSSON J, Ohlsson C, Karlsson MK, Lorentzon M, et al
    Subclinical hyperthyroidism is associated with increased risk of vertebral fractures in older men.
    Osteoporos Int. 2021 May 19. pii: 10.1007/s00198-021-05964.
    >> Share

  440. HAGINO H, Sugimoto T, Tanaka S, Sone T, et al
    A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05.
    Osteoporos Int. 2021 May 17. pii: 10.1007/s00198-021-05996.
    >> Share

  441. CARDOZO B, Karatza E, Karalis V
    Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.
    Osteoporos Int. 2021 May 17. pii: 10.1007/s00198-021-05944.
    >> Share

  442. ANASTASILAKIS AD, Makras P, Doulgeraki A, Polyzos SA, et al
    Denosumab for the treatment of primary pediatric osteoporosis.
    Osteoporos Int. 2021 May 13. pii: 10.1007/s00198-021-06002.
    >> Share

  443. CHANG CB, Yang RS, Chang LY, Peng JK, et al
    One-year outcomes of an osteoporosis liaison services program initiated within a healthcare system.
    Osteoporos Int. 2021 May 6. pii: 10.1007/s00198-021-05859.
    >> Share

  444. LIU JJ, Fu SB, Jiang J, Tang XL, et al
    Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis.
    Osteoporos Int. 2021 May 6. pii: 10.1007/s00198-021-05961.
    >> Share

  445. CASELLA M, Becciolini A, Di Donato E, Basaglia M, et al
    Internal medicine inpatients' prevalence of misdiagnosed severe osteoporosis.
    Osteoporos Int. 2021 May 5. pii: 10.1007/s00198-021-05976.
    >> Share

  446. JUNG YW, Hong N, Kim CO, Kim HC, et al
    The diagnostic value of phase angle, an integrative bioelectrical marker, for identifying individuals with dysmobility syndrome: the Korean Urban-Rural Elderly study.
    Osteoporos Int. 2021;32:939-949.
    >> Share

    April 2021
  447. SKIBICKI HE, Ponzio DY, Brustein JA, Post ZD, et al
    A cautionary case: osteoporotic femur fracture after robotic-assisted total knee arthroplasty.
    Osteoporos Int. 2021 Apr 30. pii: 10.1007/s00198-021-05977.
    >> Share

  448. YAMAMOTO Y, Chiba T, Dohmae S, Higashi K, et al
    Osteoporosis medication after fracture in older adults: an administrative data analysis.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05973.
    >> Share

  449. GU KD, Ettinger B, Grimsrud CD, Lo JC, et al
    Progression of atypical femur stress fracture after discontinuation of bisphosphonate therapy.
    Osteoporos Int. 2021 Apr 29. pii: 10.1007/s00198-021-05948.
    >> Share

  450. LYLES KW, Bauer DC, Colon-Emeric CS, Pieper CF, et al
    Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density.
    Osteoporos Int. 2021 Apr 27. pii: 10.1007/s00198-021-05923.
    >> Share

  451. KIM JT, Cha YH, Jeong S, Yoo JI, et al
    Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report.
    Osteoporos Int. 2021 Apr 24. pii: 10.1007/s00198-021-05971.
    >> Share

  452. LIU ZM, Huang Q, Li SY, Liu YP, et al
    A 1:1 matched case-control study on dietary protein intakes and hip fracture risk in Chinese elderly men and women.
    Osteoporos Int. 2021 Apr 22. pii: 10.1007/s00198-021-05960.
    >> Share

  453. TENG Z, Zhu Y, Teng Y, Long Q, et al
    The analysis of osteosarcopenia as a risk factor for fractures, mortality, and falls.
    Osteoporos Int. 2021 Apr 20. pii: 10.1007/s00198-021-05963.
    >> Share

  454. HAUGER AV, Holvik K, Bergland A, Stahle A, et al
    Physical capability, physical activity, and their association with femoral bone mineral density in adults aged 40 years and older: The Tromso study 2015-2016.
    Osteoporos Int. 2021 Apr 16. pii: 10.1007/s00198-021-05949.
    >> Share

  455. HIDAYAT K, Fang QL, Shi BM, Qin LQ, et al
    Influence of glycemic control and hypoglycemia on the risk of fracture in patients with diabetes mellitus: a systematic review and meta-analysis of observational studies.
    Osteoporos Int. 2021 Apr 16. pii: 10.1007/s00198-021-05934.
    >> Share

  456. SI L, Eisman JA, Winzenberg T, Sanders KM, et al
    Development and validation of the risk engine for an Australian Health Economics Model of Osteoporosis.
    Osteoporos Int. 2021 Apr 15. pii: 10.1007/s00198-021-05955.
    >> Share

  457. BARAKE M, El Eid R, Ajjour S, Chakhtoura M, et al
    Osteoporotic hip and vertebral fractures in the Arab region: a systematic review.
    Osteoporos Int. 2021 Apr 7. pii: 10.1007/s00198-021-05937.
    >> Share

  458. DUSSAULT PM, McCarthy D, Davis SA, Thakore-James M, et al
    High prevalence of vertebral fractures in seizure patients with normal bone density receiving chronic anti-epileptic drugs.
    Osteoporos Int. 2021 Apr 6. pii: 10.1007/s00198-021-05926.
    >> Share

  459. PLUSKIEWICZ W, Adamczyk P, Drozdzowska B
    Height loss in postmenopausal women-do we need more for fracture risk assessment? Results from the GO Study.
    Osteoporos Int. 2021 Apr 5. pii: 10.1007/s00198-021-05941.
    >> Share

  460. KANIS JA, Johansson H, Harvey NC, Lorentzon M, et al
    An assessment of intervention thresholds for very high fracture risk applied to the NOGG guidelines : A report for the National Osteoporosis Guideline Group (NOGG).
    Osteoporos Int. 2021 Apr 4. pii: 10.1007/s00198-021-05942.
    >> Share

  461. DATTA HK, Vila J, Tuck SP
    Long-term evaluation of anabolic and anti-resorptive agents in adults with familial osteoporosis due to pro205ala variant of the col1a1 gene.
    Osteoporos Int. 2021 Apr 2. pii: 10.1007/s00198-021-05933.
    >> Share

  462. CHEN FP, Fu TS, Lin YC, Lin YJ, et al
    Addition of dexamethasone to manage acute phase responses following initial zoledronic acid infusion.
    Osteoporos Int. 2021;32:663-670.
    >> Share

    March 2021
  463. HAGINO H, Tanaka K, Silverman S, McClung M, et al
    Cost effectiveness of romosozumab versus teriparatide for severe postmenopausal osteoporosis in Japan.
    Osteoporos Int. 2021 Mar 27. pii: 10.1007/s00198-021-05927.
    >> Share

  464. TOMINAGA A, Wada K, Okazaki K, Nishi H, et al
    Early clinical effects, safety, and predictors of the effects of romosozumab treatment in osteoporosis patients: one-year study.
    Osteoporos Int. 2021 Mar 26. pii: 10.1007/s00198-021-05925.
    >> Share

  465. SKJODT MK, Ernst MT, Khalid S, Libanati C, et al
    The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.
    Osteoporos Int. 2021 Mar 15. pii: 10.1007/s00198-021-05890.
    >> Share

  466. FUGGLE NR, Singer A, Gill C, Patel A, et al
    Correction to: How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.
    Osteoporos Int. 2021 Mar 9. pii: 10.1007/s00198-021-05905.
    >> Share

  467. GIRGIS CM, Clifton-Bligh RJ
    Reply to Comment on "Osteoporosis in the Age of COVID-19".
    Osteoporos Int. 2021 Mar 4. pii: 10.1007/s00198-021-05901.
    >> Share

  468. BARTOSCH P, Malmgren L, Kristensson J, McGuigan FE, et al
    In community-dwelling women frailty is associated with imminent risk of osteoporotic fractures.
    Osteoporos Int. 2021 Mar 4. pii: 10.1007/s00198-021-05886.
    >> Share

  469. BARZILAY JI, Buzkova P, Djousse L, Ix J, et al
    Serum non-esterified fatty acid levels and hip fracture risk: The Cardiovascular Health Study.
    Osteoporos Int. 2021 Mar 2. pii: 10.1007/s00198-021-05897.
    >> Share

  470. WINZENRIETH R, Ominsky MS, Wang Y, Humbert L, et al
    Differential effects of abaloparatide and teriparatide on hip cortical volumetric BMD by DXA-based 3D modeling.
    Osteoporos Int. 2021;32:575-583.
    >> Share

  471. ZULLO AR, Lee Y, Lary C, Daiello LA, et al
    Comparative effectiveness of denosumab, teriparatide, and zoledronic acid among frail older adults: a retrospective cohort study.
    Osteoporos Int. 2021;32:565-573.
    >> Share

    February 2021
  472. GAO L, Jiao T, Feng Q, Wang W, et al
    Application of artificial intelligence in diagnosis of osteoporosis using medical images: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Feb 27. pii: 10.1007/s00198-021-05887.
    >> Share

  473. CHOI YJ, Shin HB, Park B, Kim DJ, et al
    Temporal change in the diagnosis and treatment rates of osteoporosis: results from the Korea National Health and Nutrition Examination Survey.
    Osteoporos Int. 2021 Feb 25. pii: 10.1007/s00198-021-05864.
    >> Share


  474. Correction to: Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.
    Osteoporos Int. 2021 Feb 24. pii: 10.1007/s00198-021-05883.
    >> Share

  475. BERGMAN J, Nordstrom A, Hommel A, Kivipelto M, et al
    Correction to: Bisphosphonates and mortality: confounding in observational studies.
    Osteoporos Int. 2021 Feb 19. pii: 10.1007/s00198-021-05884.
    >> Share

  476. SAAG K, Cosman F, De Villiers T, Langdahl B, et al
    Early changes in bone turnover and bone mineral density after discontinuation of long-term oral bisphosphonates: a post hoc analysis.
    Osteoporos Int. 2021 Feb 19. pii: 10.1007/s00198-020-05785.
    >> Share

  477. HUANG X, Chen B, Thabane L, Adachi JD, et al
    Fragility of results from randomized controlled trials supporting the guidelines for the treatment of osteoporosis: a retrospective analysis.
    Osteoporos Int. 2021 Feb 17. pii: 10.1007/s00198-021-05865.
    >> Share

  478. YANG BR, Cha SH, Lee KE, Kim JW, et al
    Effect of dipeptidyl peptidase IV inhibitors, thiazolidinedione, and sulfonylurea on osteoporosis in patients with type 2 diabetes: population-based cohort study.
    Osteoporos Int. 2021 Feb 16. pii: 10.1007/s00198-020-05801.
    >> Share

  479. DRIESSEN JHM, van Dort MJ, Romme EAPM, Wouters EFM, et al
    Associations between bone attenuation and prevalent vertebral fractures on chest CT scans differ with vertebral fracture locations.
    Osteoporos Int. 2021 Feb 16. pii: 10.1007/s00198-020-05719.
    >> Share

  480. DELSMANN MM, Strahl A, Muhlenfeld M, Jandl NM, et al
    High prevalence and undertreatment of osteoporosis in elderly patients undergoing total hip arthroplasty.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05881.
    >> Share

  481. HSU HE, Hsu YP, Yu CH
    Multiple vertebral compression fractures in a human immunodeficiency virus-positive patient with glucocorticoid-induced Cushing syndrome treated with percutaneous vertebroplasty: a case report.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05880.
    >> Share

  482. ERWIN J, Enki DG, Woolf AD
    Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study.
    Osteoporos Int. 2021 Feb 11. pii: 10.1007/s00198-021-05862.
    >> Share

  483. MICHALSKI AS, Besler BA, Burt LA, Boyd SK, et al
    Opportunistic CT screening predicts individuals at risk of major osteoporotic fracture.
    Osteoporos Int. 2021 Feb 10. pii: 10.1007/s00198-021-05863.
    >> Share

  484. EASTMAN K, Gerlach M, Piec I, Greeves J, et al
    Effectiveness of parathyroid hormone (PTH) analogues on fracture healing: a meta-analysis.
    Osteoporos Int. 2021 Feb 9. pii: 10.1007/s00198-021-05847.
    >> Share

  485. SINGER AJ, Fuggle NR, Gill CB, Patel AR, et al
    COVID-19 and effects on osteoporosis management: the patient perspective from a National Osteoporosis Foundation survey.
    Osteoporos Int. 2021 Feb 8. pii: 10.1007/s00198-021-05836.
    >> Share

  486. FUGGLE NR, Singer A, Gill C, Patel A, et al
    How has COVID-19 affected the treatment of osteoporosis? An IOF-NOF-ESCEO global survey.
    Osteoporos Int. 2021 Feb 8. pii: 10.1007/s00198-020-05793.
    >> Share

  487. CONSTABLE AM, Vlachopoulos D, Barker AR, Moore SA, et al
    The independent and interactive associations of physical activity intensity and vitamin D status with bone mineral density in prepubertal children: the PANIC Study.
    Osteoporos Int. 2021 Feb 5. pii: 10.1007/s00198-021-05872.
    >> Share

  488. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    The effect on subsequent fracture risk of age, sex, and prior fracture site by recency of prior fracture.
    Osteoporos Int. 2021 Feb 4. pii: 10.1007/s00198-020-05803.
    >> Share

  489. MCCLOSKEY EV, Johansson H, Harvey NC, Lorentzon M, et al
    Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk: a post hoc analysis of the first year of the frame study.
    Osteoporos Int. 2021 Feb 3. pii: 10.1007/s00198-020-05815.
    >> Share

  490. ROBIN F, Cadiou S, Albert JD, Bart G, et al
    Methotrexate osteopathy: five cases and systematic literature review.
    Osteoporos Int. 2021;32:225-232.
    >> Share

    January 2021
  491. PLUSKIEWICZ W, Wilk R, Adamczyk P, Hajzyk M, et al
    The incidence of arm, forearm, and hip osteoporotic fractures during early stage of COVID-19 pandemic.
    Osteoporos Int. 2021 Jan 30. pii: 10.1007/s00198-020-05811.
    >> Share

  492. FRANCIOTTI R, Moharrami M, Quaranta A, Bizzoca ME, et al
    Use of fractal analysis in dental images for osteoporosis detection: a systematic review and meta-analysis.
    Osteoporos Int. 2021 Jan 28. pii: 10.1007/s00198-021-05852.
    >> Share

  493. CHANDRAN M, Mitchell PJ, Amphansap T, Bhadada SK, et al
    Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-020-05742.
    >> Share

  494. CRAWFORD-MANNING F, Greenall C, Hawarden A, Bullock L, et al
    Evaluation of quality and readability of online patient information on osteoporosis and osteoporosis drug treatment and recommendations for improvement.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-020-05800.
    >> Share

  495. PAUL J, Devarapalli V, Johnson JT, Cherian KE, et al
    Do proximal hip geometry, trabecular microarchitecture, and prevalent vertebral fractures differ in postmenopausal women with type 2 diabetes mellitus? A cross-sectional study from a teaching hospital in southern India.
    Osteoporos Int. 2021 Jan 27. pii: 10.1007/s00198-021-05855.
    >> Share

  496. SAHOTA O, van Berkel D, Ong T, Drummond A, et al
    Pelvic fragility fractures-the forgotten osteoporotic fracture!
    Osteoporos Int. 2021 Jan 25. pii: 10.1007/s00198-021-05848.
    >> Share

  497. OSAKI M, Okuda R, Saeki Y, Okano T, et al
    Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial.
    Osteoporos Int. 2021 Jan 23. pii: 10.1007/s00198-021-05825.
    >> Share

  498. IBRAHIMAGIC OC, Vujadinovic A, Ercegovic Z, Kunic S, et al
    Comment on an article: "Osteoporosis in the age of COVID-19 patients".
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05607.
    >> Share

  499. HOFF M, Skovlund E, Meyer HE, Langhammer A, et al
    Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway.
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-021-05845.
    >> Share

  500. LEMS WF, Paccou J, Zhang J, Fuggle NR, et al
    Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services.
    Osteoporos Int. 2021 Jan 21. pii: 10.1007/s00198-020-05804.
    >> Share

  501. GOU P, Wang Z, Zhao Z, Wang Y, et al
    Restoration of the intravertebral stability in Kummell's disease following the treatment of severe postmenopausal osteoporosis by 1-34PTH-a retrospective study.
    Osteoporos Int. 2021 Jan 20. pii: 10.1007/s00198-020-05761.
    >> Share

  502. WANDELL P, Li X, Carlsson AC, Sundquist J, et al
    Osteoporotic fractures in second-generation immigrants and Swedish natives.
    Osteoporos Int. 2021 Jan 19. pii: 10.1007/s00198-020-05776.
    >> Share

  503. LUCASSEN MJJ, Ter Wee MM, den Uyl D, Konijn NPC, et al
    Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial.
    Osteoporos Int. 2021 Jan 19. pii: 10.1007/s00198-020-05781.
    >> Share

  504. LU K, Yin Y, Li C, Jin Y, et al
    Efficacy of annual zoledronic acid in initial percutaneous kyphoplasty patients with osteoporotic vertebral compression fractures: a 3-year follow-up study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-020-05816.
    >> Share

  505. LIU CS, Feasel AL, Kline GA, Billington EO, et al
    Pharmacotherapy decisions among postmenopausal women attending a group medical consultation or a one-on-one specialist consultation at an osteoporosis center: an observational cohort study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05823.
    >> Share

  506. GUANABENS N, Olmos JM, Hernandez JL, Cerda D, et al
    Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05824.
    >> Share

  507. POWELL J, Michael A
    Peri-operative derangement in liver function tests in older patients with neck of femur fracture.
    Osteoporos Int. 2021 Jan 18. pii: 10.1007/s00198-021-05827.
    >> Share

  508. HILIGSMANN M, Maggi S, Veronese N, Sartori L, et al
    Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy.
    Osteoporos Int. 2021 Jan 14. pii: 10.1007/s00198-020-05802.
    >> Share

  509. WU YF, Lu K, Girgis C, Preda M, et al
    Postpartum bilateral sacral stress fracture without osteoporosis-a case report and literature review.
    Osteoporos Int. 2021 Jan 13. pii: 10.1007/s00198-020-05788.
    >> Share

  510. XU F, Zhang Q, Wang LK, Tang QX, et al
    Estimates of the effects of physical activity on osteoporosis using multivariable Mendelian randomization analysis.
    Osteoporos Int. 2021 Jan 13. pii: 10.1007/s00198-020-05786.
    >> Share

  511. BILLINGTON EO, Leslie WD, Brown JP, Prior JC, et al
    Simulated effects of early menopausal bone mineral density preservation on long-term fracture risk: a feasibility study.
    Osteoporos Int. 2021 Jan 12. pii: 10.1007/s00198-021-05826.
    >> Share

  512. DE VRIES BCS, Hegeman JH, Nijmeijer W, Geerdink J, et al
    Comparing three machine learning approaches to design a risk assessment tool for future fractures: predicting a subsequent major osteoporotic fracture in fracture patients with osteopenia and osteoporosis.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05735.
    >> Share

  513. XU X, Zhang M, Fei Z, Sheng H, et al
    Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05775.
    >> Share

  514. TRAN O, Silverman S, Xu X, Bonafede M, et al
    Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05769.
    >> Share

  515. SORESKOG E, Borgstrom F, Lindberg I, Strom O, et al
    A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05765.
    >> Share

  516. HANS D, Shevroja E, Leslie WD
    Evolution in fracture risk assessment: artificial versus augmented intelligence.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05737.
    >> Share

  517. YU WY, Hwang HF, Chen CY, Lin MR, et al
    Situational risk factors for fall-related vertebral fractures in older men and women.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05799.
    >> Share

  518. HAYES KN, He N, Brown KA, Cheung AM, et al
    Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05794.
    >> Share

  519. ZHANG Z, Zhou X, Shu L, Hu M, et al
    The association between overweight/obesity and vertebral fractures in older adults: a meta-analysis of observational studies.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05764.
    >> Share

  520. ICONARU L, Moreau M, Baleanu F, Kinnard V, et al
    Risk factors for imminent fractures: a substudy of the FRISBEE cohort.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05772.
    >> Share

  521. SOLLING AS, Christensen DH, Darvalics B, Harslof T, et al
    Fracture rates in patients discontinuing alendronate treatment in real life: a population-based cohort study.
    Osteoporos Int. 2021 Jan 7. pii: 10.1007/s00198-020-05745.
    >> Share

  522. SORESKOG E, Lindberg I, Kanis JA, Akesson KE, et al
    Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05780.
    >> Share

  523. ZHOU H, Li C, Song W, Wei M, et al
    Increasing fasting glucose and fasting insulin associated with elevated bone mineral density-evidence from cross-sectional and MR studies.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05762.
    >> Share

  524. ZHU Q, Xu J, Zhou M, Lian X, et al
    Association between type 1 diabetes mellitus and reduced bone mineral density in children: a meta-analysis.
    Osteoporos Int. 2021 Jan 6. pii: 10.1007/s00198-020-05715.
    >> Share

  525. WU Y, Wang F, Zhang Z
    The efficacy and safety of bisphosphonate analogs for treatment of osteoporosis after spinal cord injury: a systematic review and meta-analysis of randomized controlled trials.
    Osteoporos Int. 2021 Jan 2. pii: 10.1007/s00198-020-05807.
    >> Share

  526. SAPKOTA HR, Nune A, Bateman J, Venkatachalam S, et al
    A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic.
    Osteoporos Int. 2021;32:1-6.
    >> Share

    December 2020
  527. KRISTJANSDOTTIR HL, Mellstrom D, Johansson P, Karlsson M, et al
    High platelet count is associated with low bone mineral density: The MrOS Sweden cohort.
    Osteoporos Int. 2020 Dec 11. pii: 10.1007/s00198-020-05766.
    >> Share

  528. BURDEN AM, Tanaka Y, Xu L, Ha YC, et al
    Osteoporosis case ascertainment strategies in European and Asian countries: a comparative review.
    Osteoporos Int. 2020 Dec 10. pii: 10.1007/s00198-020-05756.
    >> Share


  529. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Author Index.
    Osteoporos Int. 2020;31.
    >> Share


  530. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Satellite Symposia Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  531. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Poster Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  532. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Non-Sponsored Symposia Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  533. World congress on osteoporosis, osteoarthritis and musculoskeletal diseases (WCO-IOF-ESCEO 2020): Committee of Scientific Advisors Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  534. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Committee of National Societies Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  535. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Meet-The-Experts Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  536. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESPRM-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  537. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): EUGMS-ESCEO-IOF Symposium Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  538. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO-WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging Symposium Abstracts (ESCEO-WHOCC).
    Osteoporos Int. 2020;31.
    >> Share


  539. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO-IOF Symposia Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  540. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): ESCEO Symposium Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  541. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Oral Communications Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  542. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Plenary Lectures Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  543. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Educational Lecture Abstracts.
    Osteoporos Int. 2020;31.
    >> Share


  544. World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2020): Special Lecture Abstract.
    Osteoporos Int. 2020;31.
    >> Share


  545. WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.
    Osteoporos Int. 2020;31.
    >> Share

  546. CAMPONOVO C, Aubry-Rozier B, Lamy O, Gonzalez Rodriguez E, et al
    Hypercalcemia upon denosumab withdrawal in primary hyperparathyroidism: a case report and literature review.
    Osteoporos Int. 2020;31:2485-2491.
    >> Share

  547. ABDALA R, Levi L, Longobardi V, Zanchetta MB, et al
    Severe bone microarchitecture deterioration in a family with hereditary neuropathy: evidence of the key role of the mechanostat.
    Osteoporos Int. 2020;31:2477-2480.
    >> Share

  548. IMEL EA, Starzyk K, Gliklich R, Weiss RJ, et al
    Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis.
    Osteoporos Int. 2020;31:2413-2424.
    >> Share

    November 2020
  549. DAHL C, Madsen C, Omsland TK, Sogaard AJ, et al
    Contribution of elevation and residential proximity to the coast in explaining geographic variations in hip fracture incidence. A Norwegian Epidemiologic Osteoporosis Studies (NOREPOS) study.
    Osteoporos Int. 2020 Nov 27. pii: 10.1007/s00198-020-05736.
    >> Share

  550. OZAKI D, Kubota R, Maeno T, Abdelhakim M, et al
    Association between gut microbiota, bone metabolism, and fracture risk in postmenopausal Japanese women.
    Osteoporos Int. 2020 Nov 25. pii: 10.1007/s00198-020-05728.
    >> Share

  551. NING HT, Du Y, Zhao LJ, Tian Q, et al
    Racial and gender differences in the relationship between sarcopenia and bone mineral density among older adults.
    Osteoporos Int. 2020 Nov 24. pii: 10.1007/s00198-020-05744.
    >> Share

  552. LANE NE, Saag K, O'Neill TJ, Manion M, et al
    Real-world bone turnover marker use: impact on treatment decisions and fracture.
    Osteoporos Int. 2020 Nov 24. pii: 10.1007/s00198-020-05734.
    >> Share

  553. MIN C, Yoo DM, Wee JH, Lee HJ, et al
    High-Intensity Physical Activity with High Serum Vitamin D Levels is Associated with a Low Prevalence of Osteopenia and Osteoporosis: A Population-Based Study.
    Osteoporos Int. 2020 Nov 23. pii: 10.1007/s00198-020-05746.
    >> Share

  554. BINKLEY N, Orwoll E, Chapurlat R, Langdahl BL, et al
    Randomized, controlled trial to assess the safety and efficacy of odanacatib in the treatment of men with osteoporosis.
    Osteoporos Int. 2020 Nov 17. pii: 10.1007/s00198-020-05701.
    >> Share

  555. ONG T, Copeland R, Thiam CN, Cerda Mas G, et al
    Integration of a vertebral fracture identification service into a fracture liaison service: a quality improvement project.
    Osteoporos Int. 2020 Nov 10. pii: 10.1007/s00198-020-05710.
    >> Share

  556. TANG C, Zhang W, Li H, Li L, et al
    CNN-based qualitative detection of bone mineral density via diagnostic CT slices for osteoporosis screening.
    Osteoporos Int. 2020 Nov 9. pii: 10.1007/s00198-020-05673.
    >> Share

  557. NG CA, McMillan LB, Humbert L, Ebeling PR, et al
    Feasibility, safety and effectiveness of a pilot 16-week home-based, impact exercise intervention in postmenopausal women with low bone mineral density.
    Osteoporos Int. 2020 Nov 7. pii: 10.1007/s00198-020-05723.
    >> Share

  558. KANIS JA, Harvey NC, Lorentzon M, Liu E, et al
    Combining fracture outcomes in phase 3 trials of osteoporosis: an analysis of the effects of denosumab in postmenopausal women.
    Osteoporos Int. 2020 Nov 6. pii: 10.1007/s00198-020-05699.
    >> Share

  559. LEE JW, Min C, Bang CH, Kwon BC, et al
    Psoriasis is associated with an increased risk of osteoporosis: follow-up and nested case-control studies using a national sample cohort.
    Osteoporos Int. 2020 Nov 5. pii: 10.1007/s00198-020-05724.
    >> Share

  560. KANIS JA, Cooper C, Dawson-Hughes B, Harvey NC, et al
    FRAX and ethnicity.
    Osteoporos Int. 2020;31:2063-2067.
    >> Share

    October 2020
  561. RANGANATH LR, Khedr M, Vinjamuri S, Gallagher JA, et al
    Frequency, diagnosis, pathogenesis and management of osteoporosis in alkaptonuria: data analysis from the UK National Alkaptonuria Centre.
    Osteoporos Int. 2020 Oct 29. pii: 10.1007/s00198-020-05671.
    >> Share

  562. RIKKONEN T, Sund R, Sirola J, Honkanen R, et al
    Obesity is associated with early hip fracture risk in postmenopausal women: a 25-year follow-up.
    Osteoporos Int. 2020 Oct 23. pii: 10.1007/s00198-020-05665.
    >> Share

  563. LARSSON BAM, Johansson L, Johansson H, Axelsson KF, et al
    The timed up and go test predicts fracture risk in older women independently of clinical risk factors and bone mineral density.
    Osteoporos Int. 2020 Oct 21. pii: 10.1007/s00198-020-05681.
    >> Share

  564. KANIS JA, Johansson H, Harvey NC, Gudnason V, et al
    The use of 2-, 5-, and 10-year probabilities to characterize fracture risk after a recent sentinel fracture.
    Osteoporos Int. 2020 Oct 20. pii: 10.1007/s00198-020-05700.
    >> Share

  565. ASANO Y, Tajiri K, Yagishita S, Nakanishi H, et al
    Correction to: Bilateral atypical ulnar fractures occurring after long-term treatment with bisphosphonate for 7 years and with teriparatide for 2 years: a case report.
    Osteoporos Int. 2020 Oct 20. pii: 10.1007/s00198-020-05679.
    >> Share

  566. MCCLOSKEY EV, Harvey NC, Johansson H, Lorentzon M, et al
    Global impact of COVID-19 on non-communicable disease management: descriptive analysis of access to FRAX fracture risk online tool for prevention of osteoporotic fractures.
    Osteoporos Int. 2020 Oct 14. pii: 10.1007/s00198-020-05542.
    >> Share

  567. LAROCHE M, Champs B, Couture G, Degboe Y, et al
    Consequence of vertebral fracture cascades: about a cohort of 79 patients.
    Osteoporos Int. 2020 Oct 14. pii: 10.1007/s00198-020-05581.
    >> Share

  568. DOMICIANO DS, Machado LG, Figueiredo CP, Caparbo VF, et al
    Incidence and risk factors for osteoporotic non-vertebral fracture in low-income community-dwelling elderly: a population-based prospective cohort study in Brazil. The Sao Paulo Ageing and Health (SPAH) study.
    Osteoporos Int. 2020 Oct 10. pii: 10.1007/s00198-020-05669.
    >> Share

  569. RONN SH, Harslof T, Oei L, Pedersen SB, et al
    The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial.
    Osteoporos Int. 2020 Oct 8. pii: 10.1007/s00198-020-05638.
    >> Share

  570. CUNDY T
    Treat-to-target-mainstream or marketing?
    Osteoporos Int. 2020;31:1835-1836.
    >> Share

    September 2020
  571. ZHU K, Zhang J, Zhang C, Zhao Z, et al
    Therapeutic efficacy of zoledronic acid combined with calcitriol in elderly patients receiving total hip arthroplasty or hemiarthroplasty for osteoporotic femoral neck fracture.
    Osteoporos Int. 2020 Sep 28. pii: 10.1007/s00198-020-05637.
    >> Share

  572. LEWIECKI EM, Wright NC, Singer AJ
    Racial disparities, FRAX, and the care of patients with osteoporosis.
    Osteoporos Int. 2020 Sep 26. pii: 10.1007/s00198-020-05655.
    >> Share

  573. TOMINAGA A, Wada K, Kato Y, Nishi H, et al
    Early clinical effects, safety, and appropriate selection of bone markers in romosozumab treatment for osteoporosis patients: a 6-month study.
    Osteoporos Int. 2020 Sep 26. pii: 10.1007/s00198-020-05639.
    >> Share

  574. GOMES-FERREIRA PHS, de Oliveira D, Frigerio PB, de Souza Batista FR, et al
    Teriparatide improves microarchitectural characteristics of peri-implant bone in orchiectomized rats.
    Osteoporos Int. 2020;31:1807-1815.
    >> Share

  575. CLYNES MA, Westbury LD, Dennison EM, Kanis JA, et al
    Bone densitometry worldwide: a global survey by the ISCD and IOF.
    Osteoporos Int. 2020;31:1779-1786.
    >> Share

    July 2020
  576. FU Y, Li C, Luo W, Chen Z, et al
    Fragility fracture discriminative ability of radius quantitative ultrasound: a systematic review and meta-analysis.
    Osteoporos Int. 2020 Jul 30. pii: 10.1007/s00198-020-05559.
    >> Share

    June 2020
  577. SALE JEM, Frankel L, Bogoch E, Gignac M, et al
    Few fragility fracture patients perceive that their bone health is affected by their comorbidities and medications.
    Osteoporos Int. 2020 Jun 5. pii: 10.1007/s00198-020-05409.
    >> Share

  578. CUMMINGS SR, McCulloch C
    Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab.
    Osteoporos Int. 2020;31:1019-1021.
    >> Share

    May 2020
  579. WHITTIER DE, Boyd SK, Burghardt AJ, Paccou J, et al
    Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography.
    Osteoporos Int. 2020 May 26. pii: 10.1007/s00198-020-05438.
    >> Share

  580. VAN DEN BERG P, van Haard PMM, Geusens PP, van den Bergh JP, et al
    Characterization of fracture liaison service non-responders after invitation by home visits and questionnaires.
    Osteoporos Int. 2020 May 13. pii: 10.1007/s00198-020-05442.
    >> Share

    April 2020
  581. LIU Y, Dash A, Krez A, Kim HJ, et al
    Low volumetric bone density is a risk factor for early complications after spine fusion surgery.
    Osteoporos Int. 2020;31:647-654.
    >> Share

  582. VAN BODEGRAVEN AA, Bravenboer N
    Perspective on skeletal health in inflammatory bowel disease.
    Osteoporos Int. 2020;31:637-646.
    >> Share

  583. GEIKER NRW, Molgaard C, Iuliano S, Rizzoli R, et al
    Impact of whole dairy matrix on musculoskeletal health and aging-current knowledge and research gaps.
    Osteoporos Int. 2020;31:601-615.
    >> Share

  584. VIETH R
    Weaker bones and white skin as adaptions to improve anthropological "fitness" for northern environments.
    Osteoporos Int. 2020;31:617-624.
    >> Share

    March 2020
  585. CHEN YJ, Kung PT, Chou WY, Tsai WC, et al
    Alendronate medication possession ratio and the risk of second hip fracture: an 11-year population-based cohort study in Taiwan.
    Osteoporos Int. 2020 Mar 27. pii: 10.1007/s00198-020-05399.
    >> Share

  586. GRIZZO FMF, Alarcao ACJ, Dell' Agnolo CM, Pedroso RB, et al
    How does women's bone health recover after lactation? A systematic review and meta-analysis.
    Osteoporos Int. 2020;31:413-427.
    >> Share

  587. OHBAYASHI Y, Iwasaki A, Nakai F, Mashiba T, et al
    A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.
    Osteoporos Int. 2020;31:577-585.
    >> Share

    February 2020
  588. HOLLICK RJ, McKee L, Shim J, Ramsay N, et al
    Introducing mobile fracture prevention services with DXA in Northern Scotland: a comparative study of three rural communities.
    Osteoporos Int. 2020 Feb 21. pii: 10.1007/s00198-020-05316.
    >> Share

  589. ALARCON T, Ojeda-Thies C, Saez-Lopez P, Gomez-Campelo P, et al
    Usefulness of a national hip fracture registry to evaluate the profile of patients in whom antiosteoporotic treatment is prescribed following hospital discharge.
    Osteoporos Int. 2020 Feb 20. pii: 10.1007/s00198-020-05341.
    >> Share

  590. LAU EMC, Dinavahi R, Woo YC, Wu CH, et al
    Romosozumab or alendronate for fracture prevention in East Asian patients: a subanalysis of the phase III, randomized ARCH study.
    Osteoporos Int. 2020 Feb 11. pii: 10.1007/s00198-020-05324.
    >> Share

    January 2020
  591. RUIZ-ADAME M, Correa M
    A systematic review of the indirect and social costs studies in fragility fractures.
    Osteoporos Int. 2020 Jan 30. pii: 10.1007/s00198-020-05319.
    >> Share

  592. MUGNIER B, Daumas A, Doddoli S, Belmeliani S, et al
    Adherence to fracture liaison service programs in patients over 70: the hidden part of the iceberg.
    Osteoporos Int. 2020 Jan 11. pii: 10.1007/s00198-020-05290.
    >> Share

  593. CHIU WY, Lin CJ, Yang WS, Tsai KS, et al
    Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women.
    Osteoporos Int. 2020;31:193-201.
    >> Share

    December 2019
  594. RASMUSSEN NH, Dal J, de Vries F, van den Bergh JP, et al
    Diabetes and fractures: new evidence of atypical femoral fractures?
    Osteoporos Int. 2019 Dec 14. pii: 10.1007/s00198-019-05224.
    >> Share

  595. EBELING PR, Chan DC, Lau TC, Lee JK, et al
    Secondary prevention of fragility fractures in Asia Pacific: an educational initiative.
    Osteoporos Int. 2019 Dec 1. pii: 10.1007/s00198-019-05197.
    >> Share

    September 2019
  596. GONZALEZ-QUEVEDO D, Bautista-Enrique D, Perez-Del-Rio V, Bravo-Bardaji M, et al
    Fracture liaison service and mortality in elderly hip fracture patients: a prospective cohort study.
    Osteoporos Int. 2019 Sep 11. pii: 10.1007/s00198-019-05153.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016